PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS
The present invention relates to pesticidally active, in particular insecticidally active heterocyclic derivatives containing sulfur substituents, to processes for their preparation, to compositions comprising those compounds, and to their use for controlling animal pests, including arthropods and in particular insects or representatives of the order Acarina. Heterocyclic compounds with pesticidal action are known and described, for example, in WO 2014/123206, WO 2014/132972 and WO 2015/121136. There have now been found novel pesticidally active heterocyclic acyl sulfilimine and sulfoximine derivatives with sulfur containing phenyl and pyridyl substituents. The present invention accordingly relates to compounds of formula I, wherein A is CH or N; X is S, SO or SO2; R1is C1-C4alkyl, C1-C4haloalkyl or C3-C6cycloalkyl-C1-C4alkyl; R7and R8are, independently from each other, C1-C6alkyl, C1-C6haloalkyl, C3-C6cycloalkyl, C1-C6cyanoalkyl, C1-C4alkoxyC1-C4alkyl, pyridyl or phenyl, wherein said pyridyl or phenyl can be mono- or polysubstituted by substituents selected from the group consisting of halogen, cyano, C1-C4alkyl, C1-C4haloalkyl, C1-C4haloalkoxy, C1-C4alkoxy, C1-C4haloalkylsulfanyl, C1-C4haloalkylsulfinyl, C1-C4haloalkylsulfonyl and —C(O)C1-C4haloalkyl; or R7and R8, together with the sulfur atom to which they are attached, form a four- to six-membered, saturated ring system, said ring system can be mono- or polysubstituted by substituents selected from the group consisting of halogen, cyano, C1-C4alkyl, C1-C4alkoxy and C1-C4haloalkyl; and said ring system may contain one heteroatom selected from the group consisting of nitrogen, oxygen and sulfur; n is 0 or 1; Q is a radical selected from the group consisting of formula Q1to Q4 wherein the arrow denotes the point of attachment to the ring incorporating the radical A; and wherein X1is O, S or NR3, wherein R3is C1-C4alkyl; R2is halogen, C1-C6haloalkyl, C1-C4haloalkylsulfanyl, C1-C4haloalkylsulfinyl, C1-C4haloalkylsulfonyl or C1-C6haloalkoxy; G1is N or CH; G2and G3are, independently from each other, N or CH; and agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula I. Compounds of formula I which have at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrose acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as C1-C4alkanecarboxylic acids which are unsubstituted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid, or with organic sulfonic acids, such as C1-C4alkane- or arylsulfonic acids which are unsubstituted or substituted, for example by halogen, for example methane- or p-toluenesulfonic acid. Compounds of formula I which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine. The alkyl groups occurring in the definitions of the substituents can be straight-chain or branched and are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, pentyl, hexyl, nonyl, decyl and their branched isomers. Alkylsulfanyl, alkylsulfinyl, alkylsulfonyl, alkoxy, alkenyl and alkynyl radicals are derived from the alkyl radicals mentioned. The alkenyl and alkynyl groups can be mono- or polyunsaturated. Halogen is generally fluorine, chlorine, bromine or iodine. This also applies, correspondingly, to halogen in combination with other meanings, such as haloalkyl or halophenyl. Haloalkyl groups preferably have a chain length of from 1 to 6 carbon atoms. Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoroethyl and 2,2,2-trichloroethyl; preferably trichloromethyl, difluorochloromethyl, difluoromethyl, trifluoromethyl and dichlorofluoromethyl. Alkoxy groups preferably have a preferred chain length of from 1 to 6 carbon atoms. Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy and tert-butoxy and also the isomeric pentyloxy and hexyloxy radicals; preferably methoxy and ethoxy. Alkoxyalkyl groups preferably have a chain length of 1 to 6 carbon atoms, more preferably a chain length of 1 to 4 carbon atoms. Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n-propoxymethyl, n-propoxyethyl, isopropoxymethyl or isopropoxyethyl. Alkylsulfanyl is for example methylsulfanyl, ethylsulfanyl, propylsulfanyl, isopropylsulfanyl, butylsulfanyl, pentylsulfanyl, and hexylsulfanyl. Alkylsulfinyl is for example methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, a butylsulfinyl, pentylsulfinyl, and hexylsulfinyl. Alkylsulfonyl is for example methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, pentylsulfonyl, and hexylsulfonyl. The cycloalkyl groups preferably have from 3 to 6 ring carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. Haloalkoxy groups preferably have a chain length of from 1 to 4 carbon atoms. Haloalkoxy is, for example, difluoromethoxy, trifluoromethoxy or 2,2,2-trifluoroethoxy. Haloalkylsulfanyl groups preferably have a chain length of from 1 to 4 carbon atoms. Haloalkylsulfanyl is, for example, difluoromethylsulfanyl, trifluoromethylsulfanyl or 2,2,2-trifluoroethylsulfanyl. Similar considerations apply to the radicals C1-C4haloalkylsulfinyl and C1-C4haloalkylsulfonyl, which may be, for example, trifluoromethylsulfinyl, trifluoromethylsulfonyl or 2,2,2-trifluoroethylsulfonyl. In the context of this invention “mono- to polysubstituted” in the definition of the substituents, means typically, depending on the chemical structure of the substituents, monosubstituted to four-times substituted, preferably monosubstituted to three-times substituted, more preferably mono-, or double-substituted. Free radicals represents methyl groups. The compounds of formula I according to the invention also include hydrates which may be formed during the salt formation. Preferred values of X1, Q, R1, R2, R7, R8, X, A and n are, in any combination thereof, as set out below: Preferably X1is NR3, wherein R3is C1-C4alkyl. Most preferably X1is NCH3. Preferably Q is a radical selected from the group consisting of formula Q1a, Q1b, Q2a, Q3aand Q4a wherein the arrow denotes the point of attachment to the ring incorporating the radical A. Most preferably Q is the radical Q1a, Q1b or Q2a. Preferably R1is C1-C4alkyl or C3-C6cycloalkyl-C1-C4alkyl. More preferably R1is C1-C4alkyl or cyclopropylmethyl. Even more preferably R1is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. Most preferably R1is ethyl. Preferably R2is halogen, C1-C4haloalkyl, C1-C4haloalkylsulfanyl, C1-C4haloalkylsulfinyl or C1-C4haloalkylsulfonyl. More preferably R2is halogen or C1-C3haloalkyl. Even more preferably R2is C1-C2haloalkyl. Most preferably R2is trifluoromethyl. Preferably R7and R8are each independently C1-C6alkyl; or R7and R8together with the sulfur atom to which they are attached form a four- to six-membered saturated ring system, which can contain one oxygen atom. More preferably R7and R8are each independently C1-C4alkyl; or R7and R8together with the sulfur atom to which they are attached form a four- or five-member membered saturated ring system, without an oxygent atom, or a six-membered saturated ring system, which can contain one oxygen atom. Even more preferably R7and R8are each independently methyl, ethyl, n-propyl or isopropyl; or R7and R8together with the sulfur atom to which they are attached form a four-membered saturated ring system, without an oxygen atom, or a six-membered saturated ring system which contains one oxygen atom (most preferably the six-membered saturated ring system is —CH2CH2OCH2CH2—). Most preferably R7is methyl and R8is ethyl; or R7and R8are both methyl; or R7and R8are both ethyl. Preferably X is S or SO2. Most preferably X is SO2. Preferably A is N. Preferably n is 1. Embodiments according to the invention are provided as set out below. Embodiment 1 provides compounds of formula I, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, as defined above. Embodiment 2 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to embodiment 1 wherein Q is a radical selected from the group consisting of formula Q1a, Q1b, Q2a, Q3aand Q4a wherein the arrow denotes the point of attachment to the ring incorporating the radical A. Embodiment 3 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to embodiment 1 or 2 wherein R1is C1-C4alkyl or C3-C6cycloalkyl-C1-C4alkyl. Embodiment 4 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2 or 3 wherein R2is halogen, C1-C4haloalkyl, C1-C4haloalkylsulfanyl, C1-C4haloalkylsulfinyl or C1-C4haloalkylsulfonyl. Embodiment 5 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3 or 4 wherein R7and R8are each independently C1-C6alkyl; or R7and R8together with the sulfur atom to which they are attached form a four- to six-membered saturated ring system, which can contain one oxygen atom. Embodiment 6 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, or 5 wherein X is S or SO2. Embodiment 7 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, or 6 wherein R1is C4alkyl or cyclopropylmethyl. Embodiment 8 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, or 7 wherein R2is halogen or C1-C6haloalkyl. Embodiment 9 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, or 8 wherein R7and R8are each independently C1-C4alkyl; or R7and R8together with the sulfur atom to which they are attached form a four- or five-member membered saturated ring system, without an oxygent atom, or a six-membered saturated ring system, which can contain one oxygen atom. Embodiment 10 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, or 9 wherein X is SO2. Embodiment 11 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 wherein R1is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. Embodiment 12 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 wherein R2is C1-C2haloalkyl. Embodiment 13 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 wherein R7and R8are each independently methyl, ethyl, n-propyl or isopropyl; or R7and R8together with the sulfur atom to which they are attached form a four-membered saturated ring system, without an oxygen atom, or a six-membered saturated ring system which contains one oxygen atom (most preferably the six-membered saturated ring system is —CH2CH2OCH2CH2—). Embodiment 14 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13 wherein R1is ethyl. Embodiment 15 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 wherein R2is trifluoromethyl. Embodiment 16 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15 wherein R7is methyl and R8is ethyl; or R7and R8are both methyl; or R7and R8are both ethyl. Embodiment 17 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 wherein Q is the radical Qia. Embodiment 18 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 wherein Q is the radical QM. Embodiment 19 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 wherein Q is the radical Q2a. Embodiment 20 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 wherein Q is the radical Q3a. Embodiment 21 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 wherein Q is the radical Q4a. Embodiment 22 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or 21 wherein A is N. Embodiment 23 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or 21 wherein A is CH. Embodiment 24 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22 or 23 wherein n is 0. Embodiment 25 provides compounds, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, according to any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22 or 23 wherein n is 1. A preferred group of compounds of formula I is represented by the compounds of formula I-1 wherein Q, A, n, R7and R8are as defined under formula I above; and wherein Xa1is S, SO or SO2; Ra1is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. In said preferred group of compounds of formula I-1, A is preferably N, Xa1is preferably S or SO2, more preferably SO2, and Ra1is preferably ethyl. In a further preferred group of compounds of formula I-1, A is preferably CH, Xa1is preferably S or SO2, more preferably SO2, and Ra1is preferably ethyl. In another preferred group of compounds of formula I-1, n is 0 or 1, preferably n is 1, and R7and R8are, independently from each other, C1-C6alkyl, even more preferably methyl or ethyl. In yet another preferred group of compounds of formula I-1, n is 0 or 1, preferably n is 1, and R7and R8, together with the sulfur atom to which they are attached, form a four- to six-membered, saturated ring system, which can contain one oxygen atom; preferably said ring system is unsubstituted, and said ring system contains no or one oxygen atom. A further preferred embodiment of said especially preferred groups of compounds of formula I-1 comprises compounds wherein A is N or CH; Xa1is preferably SO2; Ra1is preferably ethyl; n is 0 or 1; and R7and R8are, independently from each other, C1-C6alkyl, even more preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, which can contain one oxygen atom; preferably said ring system is unsubstituted, and said ring system contains one oxygen atom;
In compounds of formula I-1 and all of the preferred embodiments of compounds of formula I-1 mentioned above, Q is preferably selected from Q1and Q2, wherein X1, R2, G1and G3are as defined under formula I above. In said especially preferred group of compounds of formula I-1, X1is preferably NR3, in which R3is C1-C4alkyl, more preferably methyl; R2is preferably C1-C6haloalkyl, more preferably trifluoromethyl; G1is CH or N; and G3 is preferably N. In another preferred embodiment of compounds of formula I-1 and all of the preferred embodiments of compounds of formula I-1 mentioned above, Q is preferably selected from Q1to 04, wherein X1, R2, G1, G2and G3are as defined under formula I above. In said especially preferred group of compounds of formula I-1, X1is preferably NR3, in which R3is C1-C4alkyl, more preferably methyl; R2is preferably C1-C6haloalkyl, more preferably trifluoromethyl; G1is CH or N, more preferably G1is CH or N when Q is Q1and G1is N when Q is Q4; G2is preferably CH; and G3is preferably N. A further preferred group of compounds of formula I is represented by the compounds of formula I-2 wherein X1, R2, G1, A, n, R7and R8are as defined under formula I above; and wherein Xa2is S, SO or SO2; Ra2is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. In said preferred group of compounds of formula I-2, A is preferably N; Xa2is preferably S or SO2, more preferably SO2; and Ra2is preferably ethyl. In a further preferred group of compounds of formula I-2, A is preferably CH; Xa2is preferably S or SO2, more preferably SO2; and Ra2is preferably ethyl. In another preferred group of compounds of formula I-2, X1is preferably NR3, in which R8is C1-C4alkyl, more preferably methyl; R2is preferably C1-C6haloalkyl, more preferably trifluoromethyl; and G1is CH or N. In compounds of formula I-2 and all of the preferred embodiments of compounds of formula I-2 mentioned above, n is 0 or 1, more preferably n is 1; and R7and R8are as defined under formula I above. A further preferred embodiment of said especially preferred group of compounds of formula I-2 comprises compounds wherein R7and R8are, independently from each other, C1-C6alkyl, even more preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a four- to six-membered, saturated ring system, which can contain one oxygen atom; preferably said ring system is unsubstituted, and said ring system contains no or one oxygen atom; or more preferably R7and R8, together with the sulfur atom to which they are attached, form either a four-membered, saturated and unsubstituted ring system, which contains no oxygen atom or a six-membered, saturated and unsubstituted ring system, which contains one oxygen atom. Another preferred group of compounds of formula I is represented by the compounds of formula I-3 wherein A is N; R2is C1-C6haloalkyl, preferably trifluoromethyl; G1is N or CH; n is 0 or 1, preferably n is 1; R7and R8are, independently from each other, C1-C6alkyl, preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, which can contain one oxygen atom; preferably said ring system is unsubstituted, and said ring system contains one oxygen atom; or R7and R8, together with the sulfur atom to which they are attached, form a four-membered, saturated ring system, which contains no oxygen atom; preferably said ring system is unsubstituted. A further preferred group of compounds of formula I is represented by the compounds of formula I-4 wherein R2, G3, A, n, R7and R8are as defined under formula I above; and wherein Xa3 is S, SO or SO2; Ra3is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. In said preferred group of compounds of formula I-4, A is CH or N; Xa3is preferably S or SO2, more preferably SO2; and Ra3is preferably ethyl. In another preferred group of compounds of formula I-4, R2is preferably C1-C6haloalkyl, more preferably trifluoromethyl; and G3is CH or N, preferably N. In compounds of formula I-4 and all of the preferred embodiments of compounds of formula I-4 mentioned above, n is 0 or 1, more preferably n is 1; and R7and R8are as defined under formula I above. A further preferred embodiment of said especially preferred group of compounds of formula I-4 comprises compounds wherein R7and R8are, independently from each other, C1-C6alkyl, even more preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a four- to six-membered, saturated ring system, which can contain one oxygen atom; preferably said ring system is unsubstituted, and said ring system contains no or one oxygen atom; or more preferably R7and R8, together with the sulfur atom to which they are attached, form a four-membered, saturated and unsubstituted ring system, which contains no oxygen atom. Another preferred group of compounds of formula I is represented by the compounds of formula I-5 wherein A is CH or N; R2is C1-C6haloalkyl, preferably trifluoromethyl; G3is N or CH, preferably N; n is 0 or 1, preferably n is 1; R7and R8are, independently from each other, C1-C6alkyl, preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, which can contain one oxygen atom; preferably said ring system is unsubstituted, and said ring system contains one oxygen atom; or R7and R8, together with the sulfur atom to which they are attached, form a four-membered, saturated ring system, which contains no oxygen atom; preferably said ring system is unsubstituted. Another preferred group of compounds of formula I is represented by the compounds of formula I-5-A wherein A is CH or N; R2is C1-C6haloalkyl, preferably trifluoromethyl; G3is N;
R7and R8are, independently from each other, C1-C6alkyl, preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a four-membered, saturated ring system, which contains no oxygen atom; preferably said ring system is unsubstituted. A further preferred group of compounds of formula I is represented by the compounds of formula I-6 wherein X1, R2, G1, A, n, R7and R8are as defined under formula I above; and wherein Xa4is S, SO or SO2; Ra4is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. In said preferred group of compounds of formula I-6, A is preferably N; Xa4is preferably S or SO2, more preferably SO2; and Ra4is preferably ethyl. In a further preferred group of compounds of formula I-6, A is preferably CH; Xa4is preferably S or SO2, more preferably SO2; and Ra4is preferably ethyl. In another preferred group of compounds of formula I-6, X1is preferably NR3, in which R8is C1-C4alkyl, more preferably methyl; R2is preferably C1-C6haloalkyl, more preferably trifluoromethyl; and G1is CH or N, more preferably N. In compounds of formula I-6 and all of the preferred embodiments of compounds of formula I-6 mentioned above, n is 0 or 1, more preferably n is 1; and R7and R8are as defined under formula I above. A further preferred embodiment of said especially preferred group of compounds of formula I-6 comprises compounds wherein R7and R8are, independently from each other, C1-C6alkyl, even more preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a four- to six-membered, saturated ring system, preferably said ring system is unsubstituted, and said ring system contains no or one oxygen atom; or more preferably R7and R8, together with the sulfur atom to which they are attached, form either a four-membered, saturated and unsubstituted ring system, which contains no oxygen atom or a six-membered, saturated and unsubstituted ring system, which contains one oxygen atom. Another preferred group of compounds of formula I is represented by the compounds of formula I-7 wherein A is N or CH; in particular A is N; R2is C1-C6haloalkyl, preferably trifluoromethyl; G1is N or CH, preferably G1is N; n is 0 or 1, preferably n is 1; R7and R8are, independently from each other, C1-C6alkyl, preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, preferably said ring system is unsubstituted, and said ring system contains one oxygen atom; or R7and R8, together with the sulfur atom to which they are attached, form a four-membered, saturated ring system, which contains no oxygen atom; preferably said ring system is unsubstituted. Another preferred group of compounds of formula I is represented by the compounds of formula I-7-A wherein A is N or CH; R2is C1-C6haloalkyl, preferably trifluoromethyl; G1is N;
R7and R8are, independently from each other, C1-C6alkyl, preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, preferably said ring system is unsubstituted, and said ring system contains one oxygen atom; or R7and R8, together with the sulfur atom to which they are attached, form a four-membered, saturated ring system, which contains no oxygen atom; preferably said ring system is unsubstituted. A further preferred group of compounds of formula I is represented by the compounds of formula I-8 wherein R2, G2, G3, A, n, R7and R8are as defined under formula I above; and wherein Xa5is S, SO or SO2; Ra5is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. In said preferred group of compounds of formula I-8, A is N; Xa5is preferably S or SO2, more preferably SO2; and Ra5is preferably ethyl. In a further preferred group of compounds of formula I-8, A is preferably CH; Xa5is preferably S or SO2, more preferably SO2; and Ra5is preferably ethyl. In another preferred group of compounds of formula I-8, R2is preferably C1-C6haloalkyl, more preferably trifluoromethyl; G2is preferably CH; and G3is preferably N. In compounds of formula I-8 and all of the preferred embodiments of compounds of formula I-8 mentioned above, n is 0 or 1, more preferably n is 1; and R7and R8are as defined under formula I above. A further preferred embodiment of said especially preferred group of compounds of formula I-8 comprises compounds wherein R7and R8are, independently from each other, C1-C6alkyl, even more preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a four- to six-membered, saturated ring system, which can contain one oxygen atom; preferably said ring system is unsubstituted, and said ring system contains no or one oxygen atom. Another preferred group of compounds of formula I is represented by the compounds of formula I-9 wherein A is N or CH; R2is C1-C6haloalkyl, preferably trifluoromethyl; G2is preferably CH; G3is preferably N; n is 0 or 1, preferably n is 1; R7and R8are, independently from each other, C1-C6alkyl, preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, which can contain one oxygen atom; preferably said ring system is unsubstituted, and said ring system contains one oxygen atom; or R7and R8, together with the sulfur atom to which they are attached, form a four-membered, saturated ring system, which contains no oxygen atom; preferably said ring system is unsubstituted. Another preferred group of compounds of formula I is represented by the compounds of formula I-9-A wherein A is N; R2is C1-C6haloalkyl, preferably trifluoromethyl; G2is CH; G3is N; n is 1; and R7and R8are, independently from each other, C1-C6alkyl, preferably methyl or ethyl. A particularly preferred group of compounds of formula I is represented by the compounds of formula I-10 wherein A is CH or N; n is 0 or 1; R7and R8are, independently from each other, C1-C6alkyl, preferably methyl or ethyl; or R7and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, which can contain one oxygen atom; preferably said ring system is unsubstituted, and said ring system contains one oxygen atom; or R7and R8, together with the sulfur atom to which they are attached, form a four-membered, saturated ring system, which contains no oxygen atom; preferably said ring system is unsubstituted; and Q is a radical selected from the group consisting of formula Q1a, Q1b, Q2a, Q3aand Q4a in particular selected from the group consisting of formula Q1a, Q1band Q2a, wherein the arrow denotes the point of attachment to the ring incorporating the radical A; and in which R2is C1-C6haloalkyl, preferably trifluoromethyl. Compounds according to the invention may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against insects or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile, improved physico-chemical properties, or increased biodegradability). In particular, it has been surprisingly found that certain compounds of formula (I) may show an advantageous safety profile with respect to non-target arthropods, in particular pollinators such as honey bees, solitary bees, and bumble bees. Most particularly, The process according to the invention for preparing compounds of formula I is carried out in principle by methods known to those skilled in the art. More specifically, the subgroup of compounds of formula I, wherein X is SO (sulfoxide) and/or SO2(sulfone), may be obtained by means of an oxidation reaction of the corresponding sulfide compounds of formula I, wherein X is S, involving reagents such as, for example, m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, oxone, sodium periodate, sodium hypochlorite or tert-butyl hypochlorite amongst other oxidants. The oxidation reaction is generally conducted in the presence of a solvent. Examples of the solvent to be used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform; alcohols such as methanol and ethanol; acetic acid; water; and mixtures thereof. The amount of the oxidant to be used in the reaction is generally 1 to 3 moles, preferably 1 to 1.2 moles, relative to 1 mole of the sulfide compounds I to produce the sulfoxide compounds I, and preferably 2 to 2.2 moles of oxidant, relative to 1 mole of of the sulfide compounds I to produce the sulfone compounds I. Such oxidation reactions are disclosed, for example, in WO 2013/018928. The subgroup of compounds of the formula I wherein n is 1, defining compounds of the formula Ia, wherein X, R1, R7, R8, A and Q are as defined in formula I, may be prepared by reacting compounds of formula II, wherein X, R1, A and Q are as defined in formula I, and in which X00is a leaving group such as a halogen, preferably chlorine, or in which X00is a radical X01or X02(wherein the arrow denotes the point of attachment to the carbonyl C═O moiety of compound II), with a reagent HN═S(O)R7R8of the formula III (or a salt thereof), wherein R7and R8are as defined in formula I (scheme 1), optionally in presence of an acylating catalyst, such as 4-dimethylaminopyridine (DMAP), preferably in presence of a base, such as triethylamine, diisopropylethylamine or pyridine, in an inert solvent at temperatures between 0 and 50° C. Examples of solvent to be used include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butylmethyl ether, and 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile or polar aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone or dimethyl sulfoxide. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent. Compounds of formula III, wherein R7and R8are as defined in formula I, are either known compounds, commercially available or can be prepared by known methods, described in the literature, as for example in Journal of the Chemical Society, 3004-5; 1965 or e-EROS Encyclopedia of Reagents for Organic Synthesis, 1-8; 2013. Of advantage are preparation methods for compounds of formula III starting from readily available sulfide compounds of formula V (see Chem. Commun. 53, 348-351; 2017 and further references cited therein), or from the corresponding sulfoxide compounds of formula VI (see Angewandte Chemie, International Edition, 55, 7203-7207; 2016 and further references cited therein), wherein R7and R8are as defined in formula I, that involve, for example, ammonia, ammonium carbamate or ammonium acetate as a suitable nitrogen source, and mediated by hypervalent iodine reagents, such as diacetoxyiodobenzene, in solvents such as toluene, acetonitrile or methanol, at temperatures between 0 and 100° C., preferably around room temperature. Compounds of formula V and compounds of formula VI, wherein R7and R8are as defined in formula I, are either known compounds, commercially available or can be prepared by known methods, described in the literature. In particular, compounds of formula V may be oxidized to compounds of formula VI under standard oxidation conditions already described above. Alternatively, compounds of the formula Ia, wherein X, R1, R7, R8, A and Q are as defined in formula I, may be prepared by an oxidation step from the subgroup of compounds of the formula I wherein n is 0, defining compounds of the formula Ib, wherein X, R1, R7, R8, A and Q are as defined in formula I (scheme 2). In such transformations, classical oxidation reagents may be used such as, for example, KMnO4(European Journal of Organic Chemistry, 2013(34), 7800-7808; 2013), NaMnO4, mCPBA, NalO4/RuO2(Tetrahedron Letters, (6), 503-6; 1978), NalO4/RuCl3, H2O2(optionally in presence of a catalyst, such as for example sodium tungstate Na2WO4; WO07/006670), or oxone. Such oxidations may further be performed in analogy to descriptions found in, for example, WO2008/097235 and WO2008/106006, related to the use of ruthenium salts in combination with alkali metal periodates and alternatively to the use of alkali metal permanganates. Suitable solvents for the oxidation are, for example, dichloromethane, chloroform, methanol, ethanol, water or acetic acid, or mixtures thereof, at temperatures ranging from −10° to 50° C., preferably between 10 and 30° C. Compounds of the formula Ib, wherein X, R1, R7, R8, A and Q are as defined in formula I, may be prepared by reacting compounds of formula IV, wherein X, R1, A and Q are as defined in formula I, with a sulfoxide reagent S(O)R7R8of the formula VI, wherein R7and R8are as defined in formula I, for example by involving phosphorus pentoxide (Monatsh. Chem. 101, 396-404; 1970), or trifluoroacetic anhydride (J. Org. Chem. 40, 2758-2764; 1975), in presence of triethylamine, and in solvents such as chloroform or dichloromethane, at temperatures between −80 and 100° C., preferably between −70 and 60° C. Compounds of formula IV, wherein X, R1, A and Q are as defined in formula I, may be prepared by reacting compounds of formula II, wherein X, R1, A and Q are as defined in formula I, and in which X00is a leaving group such as a halogen, preferably chlorine, or in which X00is a radical X01or X02(wherein the arrow denotes the point of attachment to the carbonyl C═O moiety of compound II), with ammonia NH3(or a salt thereof) or an ammonia equivalent such as for example ammonium hydroxide NH4OH, ammonium chloride NH4Cl, ammonium acetate NH4OAc, ammonium carbonate (NH4)2CO3, and other NH3surrogates, optionally in presence of an acylating catalyst, such as 4-dimethylaminopyridine (DMAP), preferably in presence of a base, such as triethylamine, diisopropylethylamine or pyridine, in an inert solvent at temperatures between 0 and 50° C. Examples of solvent to be used include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butylmethyl ether, and 1,4-dioxane, esters such as ethyl acetate, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile or polar aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone or dimethyl sulfoxide, or water, or mixtures thereof. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent. Alternatively, compounds of the formula Ib, wherein X, R1, R7, R8, A and Q are as defined in formula I, may be prepared by reacting compounds of formula II, wherein X, R1, A and Q are as defined in formula I, and in which X00is a leaving group such as a halogen, preferably chlorine, or in which X00is a radical X01or X02(wherein the arrow denotes the point of attachment to the carbonyl C═O moiety of compound II), with a sulfilimine reagent S(NH)R7R8of the formula VII (or a salt thereof), wherein R7and R8are as defined in formula I, optionally in presence of an acylating catalyst, such as 4-dimethylaminopyridine (DMAP), preferably in presence of a base, such as triethylamine, diisopropylethylamine or pyridine, in an inert solvent at temperatures between 0 and 50° C. Examples of solvent to be used include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butylmethyl ether, and 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile or polar aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone or dimethyl sulfoxide. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent. Compounds of formula VII (or a salt thereof), wherein R7and R8are as defined in formula I, are either known compounds, commercially available or can be prepared by known methods, in particular may be prepared conveniently from sulfide compounds of formula V, wherein R7and R8are as defined in formula I, as described in the literature, as for example in Justus Liebigs Annalen der Chemie, 618, 53-8, 1958; Chemische Berichte, 99(10), 3108-17, 1966; Tetrahedron Letters, (40), 4137-40, 1972; or WO2014/053401. Compounds of formula II, wherein X, R1, A and Q are as defined in formula I, and in which X00is a leaving group such as a halogen, preferably chlorine, or in which X00is a radical X01or X02(wherein the arrow denotes the point of attachment to the carbonyl C═O moiety of compound II), may be prepared by activation of a compound of formula VIII, wherein X, R1, A and Q are as defined in formula I, by methods known to those skilled in the art and described in, for example, Tetrahedron, 2005, 61 (46), 10827-10852 (scheme 3). For example, compounds II where X00is halogen, preferably chlorine, are typically formed by treatment of compounds VIII with, for example, oxalyl chloride (COCl)2or thionyl chloride SOCl2in the presence of catalytic quantities of N,N-dimethylformamide DMF in inert solvents such as methylene chloride CH2Cl2or tetrahydrofuran THF at temperatures between 20 to 100° C., preferably 25° C. Alternatively, treatment of compounds of formula VIII with, for example, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide EDC (also known as EDAC or EDCI) or dicyclohexyl carbodiimide DCC will generate an activated species II, wherein X00is X01or X02respectively, in an inert solvent, such as pyridine or tetrahydrofuran THF, optionally in the presence of a base, such as triethylamine, at temperatures between 20-180° C. Compound of formula VIII, wherein X, R1, A and Q are as defined in formula I, may be prepared by saponification of the corresponding ester compounds of formula IX, wherein X, R1, A and Q are as defined in formula I, and in which Rx is C1-C6alkyl, under conditions known to a person skilled in the art (using for example conditions such as: aqueous sodium, potassium or lithium hydroxide in methanol, ethanol, tetrahydrofuran or dioxane at room temperature, or up to refluxing conditions). Alternatively, treating ester compounds of formula IX with halide anions, preferably chloride anions, originating from, for example, lithium chloride (or alternatively sodium or potassium chloride), in solvents such as N,N-dimethylformamide, N,N-dimethylacetamide or N-methyl-2-pyrrolidone, may also generate the carboxylic acid compounds of formula VIII. The reaction temperatures for such an O-demethylation range preferentially from 20° C. to the boiling point of the reaction mixture, or the reaction may be performed under microwave irradiation. Compounds of formula IX, wherein X, R1, A and Q are as defined in formula I, and in which Rx is C1-C6alkyl, may be prepared by a carbonylation reaction from compounds of formula (X), wherein X, R1, A and Q are as defined in formula I, and in which Xa is a leaving group such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), or an aryl-, alkyl- or haloalkylsulfonate such as trifluoromethanesulfonate. In such alkoxycarbonylations, compounds of formula (X) are reacted with carbon monoxide CO, usually under pressure, in presence of metal catalyst such as a palladium catalyst (for example: palladium(II) acetate; [1,1′-bis(diphenylphosphino)ferrocene] palladium(II) dichloride Pd(dppf)C12; bis(triphenylphosphine)palladium(II) dichloride PdCl2(PPh3)2; bis(diphenylphosphino)propane]palladium(II) PdCl2(dippp)), optionally in presence of a phosphine ligand such as triphenylphosphine or 1,1′-bis(diphenylphosphino)ferrocene, in an alcohol RxOH solvent (typically methanol or ethanol), wherein Rx is C1-C6alkyl, optionally in presence of a co-solvent (eg. toluene, dioxane or N,N-dimethylformamide), and preferably in presence of a base, such as for example trimethylamine, at temperatures between 20° and 200° C., preferably between 50° and 180° C. Alternatively, compound of formula VIII, wherein X, R1, A and Q are as defined in formula I, may be prepared (scheme 4) by hydrolysis of compounds of formula XI, wherein X, R1, A and Q are as defined in formula I, either under aqueous acidic or basic conditions (see, for example, Synthetic Organic Methodology, Comprehensive Organic Transformations: A Guide to Functional Group Preparations, Larock, R. C. 1989, p. 993). Typically, compounds of formula XI are treated with aqueous acid, such as hydrochloric acid HCl or sulfuric acid H2SO4(for example a 50% aqueous sulfuric acid solution), optionally in the presence of an inert solvent, such as ethers (for example tetrahydrofuran, ethylene glycol dimethyl ether, or 1,4-dioxane) at temperatures ranging from room temperature to 180° C., preferably between 50° C. to the boiling point of the reaction mixture. Such hydrolysis conditions, and variants thereof, are known to a person skilled in the art. Compounds of formula XI, wherein X, R1, A and Q are as defined in formula I, may be prepared by cyanation of compounds of formula (X), wherein X, R1, A and Q are as defined in formula I, and in which Xa is a leaving group such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), or an aryl-, alkyl- or haloalkylsulfonate such as trifluoromethanesulfonate. In such reactions, compounds of formula (X) are reacted with a cyanide source such as copper(I) cyanide, optionally in the presence of an additional copper catalyst, for example copper(I) iodide, in solvents such as dimethylsulfoxide, N-methyl pyrrolidone, N,N-dimethylformamide or N,N-dimethylacetamide, at temperatures between 0 and 200° C., preferably between 50 and 180° C., optionally under microwave irradiation. Alternatively, this transformation may be achieved under palladium- or nickel-catalysis with for example zinc cyanide (see for example, Med. Chem. Commun., 2010, 1, 309-318). Alternatively, compound of formula VIII, wherein X, R1, A and Q are as defined in formula I, may be prepared (scheme 5) by oxidative cleavage of alkene compounds of formula XII, wherein X, R1, A and Q are as defined in formula I, and wherein the olefin moiety may be mono-, di- or tri-substituted by Ry, and in which Ry is hydrogen, C1-C6alkyl, C1-C6alkoxy or phenyl (preferably Ry is hydrogen). Oxidative cleavage conditions comprise for example the use of osmium tetroxide OsO4(alternatively manganese, ruthenium or wolframate oxide reagents), or a surrogate thereof such as dipotassium osmate dihydrate (K2OsO4.2H2O), in the presence of a co-oxidant such as ozone (see in particular J. Am. Chem. Soc. 2002, 124, 3824-3825) or sodium periodate NalO4, in solvents such as acetone, tert-butanol, N,N-dimethylformamide or 1,4-dioxane, usually in mixtures with water, at temperatures between 0 and 80° C., preferably between 0° C. and room temperature. Such reactions may proceed with the intermediacy of the corresponding 1,2-diol and/or aldehyde originating from compounds of formula XII, which may be isolated, but advantageously olefins of formula XII are directly oxidatively cleaved to the carboxylic acids of formula VIII. Such kind of transformations involving OsO4 and NalO4 are known in literature, as described for example in Eur. J. Org. Chem. 2014, 5664-5669. Compounds of formula XII, wherein X, R1, A and Q are as defined in formula I, and wherein the olefin moiety may be mono-, di- or tri-substituted by Ry, in which Ry is hydrogen, C1-C6alkyl, C1-C6alkoxy or phenyl (preferably Ry is hydrogen) may be prepared by olefination of compounds of formula (X), wherein X, R1, A and Q are as defined in formula I, and in which Xa is a leaving group such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), or an aryl-, alkyl- or haloalkylsulfonate such as trifluoromethanesulfonate, under metal catalyzed cross-coupling reaction conditions (Modern Arylation Methods, by Lutz Ackermann, Wiley, 2009). In particular, compounds of formula XII may be prepared by a Stille reaction between compounds of formula (X) and an appropriate tin reagent (a trialkyl tin derivative, preferably tri-n-butyl tin), such as for example tributyl(vinyl)tin when Ry is preferably hydrogen. Such Stille reactions are usually carried out in the presence of a palladium catalyst, for example tetrakis(triphenylphosphine) palladium(0), or bis(triphenylphosphine)palladium(II) dichloride, in an inert solvent such as N,N-dimethylformamide, acetonitrile, toluene or dioxane, optionally in the presence of an additive, such as cesium fluoride, or lithium chloride, and optionally in the presence of a further catalyst, for example copper(I)iodide. Such Stille couplings are also well known to those skilled in the art, and have been described in for example Compounds of formula (X), wherein X, R1, A and Q are as defined in formula I, and in which Xa is a leaving group, in particular those compounds wherein Xa is a halogen, are known compounds or can be prepared by known methods or can be synthesized in analogy to described methods, found in the literature. See in particular WO 2016/071214 (Q is Q2, G3is N) and WO 2015/000715 (Q is Q2, G3is CH), WO 2016/026848 and WO 2016/005263 (Q is Q1, G1is CH), WO 2016/059145 (Q is Q1, G1is N), WO 2016/020286 and WO 2017/134066 (Q is Q3) and WO 2012/086848, WO 2013/018928 (Q is 04). Certain compounds of the formula VIII and/or IX, wherein X, R1, A and Q are as defined in formula I, and in which Rx is C1-C6alkyl, are known in the literature, see in particular WO17/146221, WO16/104746, WO14/142292, WO14/132972, and WO14/123206. The reactants can be reacted in the presence of a base. Examples of suitable bases are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkali metal or alkaline earth metal alkylsilylamides, alkylamines, alkylenediamines, free or N-alkylated saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbocyclic amines. Examples which may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). The reactants can be reacted with each other as such, i.e. without adding a solvent or diluent. In most cases, however, it is advantageous to add an inert solvent or diluent or a mixture of these. If the reaction is carried out in the presence of a base, bases which are employed in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also act as solvents or diluents. The reaction is advantageously carried out in a temperature range from approximately −80° C. to approximately +140° C., preferably from approximately −30° C. to approximately +100° C., in many cases in the range between ambient temperature and approximately +80° C. A compound of formula I can be converted in a manner known per se into another compound of formula I by replacing one or more substituents of the starting compound of formula I in the customary manner by (an)other substituent(s) according to the invention. Depending on the choice of the reaction conditions and starting materials which are suitable in each case, it is possible, for example, in one reaction step only to replace one substituent by another substituent according to the invention, or a plurality of substituents can be replaced by other substituents according to the invention in the same reaction step. Salts of compounds of formula I can be prepared in a manner known per se. Thus, for example, acid addition salts of compounds of formula I are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent. Salts of compounds of formula I can be converted in the customary manner into the free compounds I, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent. Salts of compounds of formula I can be converted in a manner known per se into other salts of compounds of formula I, acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture. Depending on the procedure or the reaction conditions, the compounds of formula I, which have salt-forming properties can be obtained in free form or in the form of salts. The compounds of formula I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can be present in the form of one of the isomers which are possible or as a mixture of these, for example in the form of pure isomers, such as antipodes and/or diastereomers, or as isomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule; the invention relates to the pure isomers and also to all isomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case. Diastereomer mixtures or racemate mixtures of compounds of formula I, in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography. Enantiomer mixtures, such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid chromatography (HPLC) on acetyl celulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the diastereomers, from which the desired enantiomer can be set free by the action of suitable agents, for example basic agents. Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry. N-oxides can be prepared by reacting a compound of the formula I with a suitable oxidizing agent, for example the H2O2/urea adduct in the presence of an acid anhydride, e.g. trifluoroacetic anhydride. Such oxidations are known from the literature, for example from J. Med. Chem., 32 (12), 2561-73, 1989 or WO 00/15615. It is advantageous to isolate or synthesize in each case the biologically more effective isomer, for example enantiomer or diastereomer, or isomer mixture, for example enantiomer mixture or diastereomer mixture, if the individual components have a different biological activity. The compounds of formula I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form. The compounds according to the following Tables 1 to 12 below can be prepared according to the methods described above. The examples which follow are intended to illustrate the invention and show preferred compounds of formula I. Table 1: This table discloses the 28 compounds 1.001 to 1.028 of the formula I-1a: wherein X11is S, and A, R11, G1, R2, n, R7and R8are as defined below: Table 2: This table discloses the 28 compounds 2.001 to 2.028 of the formula I-1a, wherein X11is SO, and A, R11, G1, R2, n, R7and R8are as defined in Table 1. Table 3: This table discloses the 28 compounds 3.001 to 3.028 of the formula I-1a, wherein X11is SO2, and A, R11, G1, R2, n, R7and R8are as defined in Table 1. Table 4: This table discloses the 26 compounds 4.001 to 4.026 of the formula I-2a: wherein X11is S, and A, R11, G3, R2, n, R7and R8are as defined below: Table 5: This table discloses the 26 compounds 5.001 to 5.026 of the formula I-2a, wherein X11is SO, and A, R11, G3, R2, n, R7and R8are as defined in Table 4. Table 6: This table discloses the 26 compounds 6.001 to 6.026 of the formula I-2a, wherein X11is SO2, and A, R11, G3, R2, n, R7and R8are as defined in Table 4. Table 7: This table discloses the 26 compounds 7.001 to 7.026 of the formula I-3a: wherein X11is S, and A, R11, G1, R2, n, R7and R8are as defined below: Table 8: This table discloses the 26 compounds 8.001 to 8.026 of the formula I-3a, wherein X11is SO, and A, R11, G1, R2, n, R7and R8are as defined in Table 7. Table 9: This table discloses the 26 compounds 9.001 to 9.026 of the formula I-3a, wherein X11is SO2, and A, R11, G1, R2, n, R7and R8are as defined in Table 7. Table 10: This table discloses the 14 compounds 10.001 to 10.014 of the formula I-4a: wherein X11is S, and A, R11, G2, G3, R2, n, R7and R8are as defined below: Table 11: This table discloses the 14 compounds 11.001 to 11.014 of the formula I-4a, wherein X11is SO, and A, R11, G2, G3, R2, n, R7and R8are as defined in Table 10. Table 12: This table discloses the 14 compounds 12.001 to 12.014 of the formula I-4a, wherein X11is SO2, and A, R11, G2, G3, R2, n, R7and R8are as defined in Table 10. The compounds of formula I according to the invention are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a very favorable biocidal spectrum and are well tolerated by warm-blooded species, fish and plants. The active ingredients according to the invention act against all or individual developmental stages of normally sensitive, but also resistant, animal pests, such as insects or representatives of the order Acarina. The insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i. e. in destruction of the pests, which takes place either immediately or only after some time has elapsed, for example during ecdysis, or indirectly, for example in a reduced oviposition and/or hatching rate, a good activity corresponding to a destruction rate (mortality) of at least 50 to 60%. Examples of the abovementioned animal pests are: from the order Acarina, for example, from the order Anoplura, for example, from the order Coleoptera, for example, from the order Hemiptera, for example, from the order Hymenoptera, for example, from the order Isoptera, for example, from the order Psocoptera, for example, from the order Siphonaptera, for example, from the order Thysanoptera, for example, from the order Thysanura, for example, The active ingredients according to the invention can be used for controlling, i. e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forests, or on organs, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some cases even plant organs which are formed at a later point in time remain protected against these pests. Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum; beet, such as sugar or fodder beet; fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries; leguminous crops, such as beans, lentils, peas or soya; oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts; cucurbits, such as pumpkins, cucumbers or melons; fibre plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruit or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes or bell peppers; Lauraceae, such as avocado, Cinnamonium or camphor; and also tobacco, nuts, coffee, eggplants, sugarcane, tea, pepper, grapevines, hops, the plantain family and latex plants. The compositions and/or methods of the present invention may be also used on any ornamental and/or vegetable crops, including flowers, shrubs, broad-leaved trees and evergreens. For example the invention may be used on any of the following ornamental species: For example the invention may be used on any of the following vegetable species: Preferred ornamental species include African violet, The active ingredients according to the invention are especially suitable for controlling The active ingredients according to the invention are especially suitable for controlling In a further aspect, the invention may also relate to a method of controlling damage to plant and parts thereof by plant parasitic nematodes (Endoparasitic-, Semiendoparasitic- and Ectoparasitic nematodes), especially plant parasitic nematodes such as root knot nematodes, The compounds of the invention may also have activity against the molluscs. Examples of which include, for example, Ampullariidae; The term “crops” is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, for example insecticidal proteins from In the context of the present invention there are to be understood by δ-endotoxins, for example Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1, Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701). Truncated toxins, for example a truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810). Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073. The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Cry1-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651. The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and moths (Lepidoptera). Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a Cry1Ab toxin); YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus® (maize variety that expresses a Cry1Ab and a Cry3Bb1 toxin); Starlink® (maize variety that expresses a Cry9C toxin); Herculex I® (maize variety that expresses a Cry1Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a Cry1Ac toxin); Bollgard I® (cotton variety that expresses a Cry1Ac toxin); Bollgard II® (cotton variety that expresses a Cry1Ac and a Cry2Ab toxin); VipCot® (cotton variety that expresses a Vip3A and a Cry1Ab toxin); NewLeaf® (potato variety that expresses a Cry3A toxin); NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait) and Protecta®. Further examples of such transgenic crops are:
Transgenic crops of insect-resistant plants are also described in BATS (Zentrum für Biosicherheit and Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) Report 2003, (http://bats.ch). The term “crops” is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called “pathogenesis-related proteins” (PRPs, see e.g. EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818 and EP-A-0 353 191. The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Antipathogenic substances which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example the viral KP1, KP4 or KP6 toxins; stilbene synthases; bibenzyl synthases; chitinases; glucanases; the so-called “pathogenesis-related proteins” (PRPs; see e.g. EP-A-0 392 225); antipathogenic substances produced by microorganisms, for example peptide antibiotics or heterocyclic antibiotics (see e.g. WO 95/33818) or protein or polypeptide factors involved in plant pathogen defence (so-called “plant disease resistance genes”, as described in WO 03/000906). Further areas of use of the compositions according to the invention are the protection of stored goods and store rooms and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type. The present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors; see also http://www.who.int/malaria/vector_control/irs/en/). In one embodiment, the method for controlling pests comprises applying the compositions of the invention to the target pests, to their locus or to a surface or substrate by brushing, rolling, spraying, spreading or dipping. By way of example, an IRS (indoor residual spraying) application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention. In another embodiment, it is contemplated to apply such compositions to a substrate such as non-woven or a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents. In one embodiment, the method for controlling such pests comprises applying a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate. Such application may be made by brushing, rolling, spraying, spreading or dipping the pesticidal composition of the invention. By way of example, an IRS application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention so as to provide effective residual pesticidal activity on the surface. In another embodiment, it is contemplated to apply such compositions for residual control of pests on a substrate such as a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents. Substrates including non-woven, fabrics or netting to be treated may be made of natural fibres such as cotton, raffia, jute, flax, sisal, hessian, or wool, or synthetic fibres such as polyamide, polyester, polypropylene, polyacrylonitrile or the like. The polyesters are particularly suitable. The methods of textile treatment are known, e.g. WO 2008/151984, WO 2003/034823, U.S. Pat. No. 5,631,072, WO 2005/64072, WO2006/128870, EP 1724392, WO2005113886 or WO 2007/090739. Further areas of use of the compositions according to the invention are the field of tree injection/trunk treatment for all ornamental trees as well all sort of fruit and nut trees. In the field of tree injection/trunk treatment, the compounds according to the present invention are especially suitable against wood-boring insects from the order Lepidoptera as mentioned above and from the order Coleoptera, especially against woodborers listed in the following tables A and B: The present invention may be also used to control any insect pests that may be present in turfgrass, including for example beetles, caterpillars, fire ants, ground pearls, millipedes, sow bugs, mites, mole crickets, scales, mealybugs ticks, spittlebugs, southern chinch bugs and white grubs. The present invention may be used to control insect pests at various stages of their life cycle, including eggs, larvae, nymphs and adults. In particular, the present invention may be used to control insect pests that feed on the roots of turfgrass including white grubs (such as The present invention may also be used to control insect pests of turfgrass that are thatch dwelling, including armyworms (such as fall armyworm The present invention may also be used to control insect pests of turfgrass that live above the ground and feed on the turfgrass leaves, including chinch bugs (such as southern chinch bugs, In the hygiene sector, the compositions according to the invention are active against ectoparasites such as hard ticks, soft ticks, mange mites, harvest mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas. Examples of such parasites are: Of the order Anoplurida: Of the order Mallophagida: Of the order Diptera and the suborders Nematocerina and Brachycerina, for example Of the order Siphonapterida, for example Of the order Heteropterida, for example Of the order Blattarida, for example Of the subclass Acaria (Acarida) and the orders Meta- and Meso- Of the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example The compositions according to the invention are also suitable for protecting against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and buildings. The compositions according to the invention can be used, for example, against the following pests: beetles such as The compounds according to the invention can be used as pesticidal agents in unmodified form, but they are generally formulated into compositions in various ways using formulation adjuvants, such as carriers, solvents and surface-active substances. The formulations can be in various physical forms, e.g. in the form of dusting powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent pellets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, oil-flowables, aqueous dispersions, oily dispersions, suspo-emulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or a water-miscible organic solvent as carrier), impregnated polymer films or in other forms known e.g. from the Manual on Development and Use of FAO and WHO Specifications for Pesticides, United Nations, First Edition, Second Revision (2010). Such formulations can either be used directly or diluted prior to use. The dilutions can be made, for example, with water, liquid fertilisers, micronutrients, biological organisms, oil or solvents. The formulations can be prepared e.g. by mixing the active ingredient with the formulation adjuvants in order to obtain compositions in the form of finely divided solids, granules, solutions, dispersions or emulsions. The active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof. The active ingredients can also be contained in very fine microcapsules. Microcapsules contain the active ingredients in a porous carrier. This enables the active ingredients to be released into the environment in controlled amounts (e.g. slow-release). Microcapsules usually have a diameter of from 0.1 to 500 microns. They contain active ingredients in an amount of about from 25 to 95% by weight of the capsule weight. The active ingredients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution. The encapsulating membranes can comprise, for example, natural or synthetic rubbers, cellulose, styrene/butadiene copolymers, polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyurethane or chemically modified polymers and starch xanthates or other polymers that are known to the person skilled in the art. Alternatively, very fine microcapsules can be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of base substance, but the microcapsules are not themselves encapsulated. The formulation adjuvants that are suitable for the preparation of the compositions according to the invention are known per se. As liquid carriers there may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethylformamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, alpha-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol acetate, glycerol diacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy-propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol, propionic acid, propyl lactate, propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol, and alcohols of higher molecular weight, such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone and the like. Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed husks, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances. A large number of surface-active substances can advantageously be used in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier prior to use. Surface-active substances may be anionic, cationic, non-ionic or polymeric and they can be used as emulsifiers, wetting agents or suspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate; salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol/alkylene oxide addition products, such as nonylphenol ethoxylate; alcohol/alkylene oxide addition products, such as tridecylalcohol ethoxylate; soaps, such as sodium stearate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and di-alkylphosphate esters; and also further substances described e.g. in McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Corp., Ridgewood N.J. (1981). Further adjuvants that can be used in pesticidal formulations include crystallisation inhibitors, viscosity modifiers, suspending agents, dyes, anti-oxidants, foaming agents, light absorbers, mixing auxiliaries, antifoams, complexing agents, neutralising or pH-modifying substances and buffers, corrosion inhibitors, fragrances, wetting agents, take-up enhancers, micronutrients, plasticisers, glidants, lubricants, dispersants, thickeners, antifreezes, microbicides, and liquid and solid fertilisers. The compositions according to the invention can include an additive comprising an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils and oil derivatives. The amount of oil additive in the composition according to the invention is generally from 0.01 to 10%, based on the mixture to be applied. For example, the oil additive can be added to a spray tank in the desired concentration after a spray mixture has been prepared. Preferred oil additives comprise mineral oils or an oil of vegetable origin, for example rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, alkyl esters of oils of vegetable origin, for example the methyl derivatives, or an oil of animal origin, such as fish oil or beef tallow. Preferred oil additives comprise alkyl esters of C8-C22fatty acids, especially the methyl derivatives of C12-C18fatty acids, for example the methyl esters of lauric acid, palmitic acid and oleic acid (methyl laurate, methyl palmitate and methyl oleate, respectively). Many oil derivatives are known from the Compendium of Herbicide Adjuvants, 10thEdition, Southern Illinois University, 2010. The inventive compositions generally comprise from 0.1 to 99% by weight, especially from 0.1 to 95% by weight, of compounds of the present invention and from 1 to 99.9% by weight of a formulation adjuvant which preferably includes from 0 to 25% by weight of a surface-active substance. Whereas commercial products may preferably be formulated as concentrates, the end user will normally employ dilute formulations. The rates of application vary within wide limits and depend on the nature of the soil, the method of application, the crop plant, the pest to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop. As a general guideline compounds may be applied at a rate of from 1 to 2000 l/ha, especially from 10 to 1000 l/ha. Preferred formulations can have the following compositions (weight %): The following Examples further illustrate, but do not limit, the invention. The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration. The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment. Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water. Ready-for-use dusts are obtained by mixing the combination with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed. The combination is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air. The finely ground combination is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner. The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion. The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion. 28 parts of the combination are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8:1). This mixture is emulsified in a mixture of 1.2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed. The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns. The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose. Formulation types include an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP), a soluble granule (SG) or any technically feasible formulation in combination with agriculturally acceptable adjuvants. “Mp” means melting point in ° C. Free radicals represent methyl groups.1H NMR measurements were recorded on a Brucker 400 MHz spectrometer, chemical shifts are given in ppm relevant to a TMS standard. Spectra measured in deuterated solvents as indicated. Either one of the LCMS methods below was used to characterize the compounds. The characteristic LCMS values obtained for each compound were the retention time (“Rt”, recorded in minutes) and the measured molecular ion (M+H)+. Spectra were recorded on a Mass Spectrometer from Waters (ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150° C., Desolvation Temperature: 350° C., Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1.8 μm, 30×2.1 mm, Temp: 60° C., DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A=water+5% MeOH+0.05% HCOOH, B=Acetonitrile+0.05% HCOOH: gradient: 0 min 0% B, 100% A; 1.2-1.5 min 100% B; Flow (ml/min) 0.85. Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150° C., Desolvation Temperature: 350° C., Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1.8 μm, 30×2.1 mm, Temp: 60° C., DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A=water+5% MeOH+0.05% HCOOH, B=Acetonitrile+0.05% HCOOH; gradient: 0 min 0% B, 100% A; 2.7-3.0 min 100% B; Flow (ml/min) 0.85. Spectra were recorded on a Mass Spectrometer from Agilent Technologies (6410 Triple Quadruple Mass Spectrometer) equipped with an electrospray source (Polarity: Positive and Negative Polarity Switch, Capillary: 4.00 kV, Fragmentor: 100.00 V, Gas Temperature: 350° C., Gas Flow: 11 L/min, Nebulizer Gas: 45 psi, Mass range: 110-1000 Da, DAD Wavelength range: 210-400 nm). Column: KINETEX EVO C18, length 50 mm, diameter 4.6 mm, particle size 2.6 μm. Column oven temperature 40° C. Solvent gradient: A=Water with 0.1% formic acid: Acetonitrile (95:5 v/v). B=Acetonitrile with 0.1% formic acid. Gradient=0 min 90% A, 10% B; 0.9-1.8 min 0% A, 100% B, 2.2-2.5 min 90% A, 10% B. Flow rate 1.8 mL/min. Spectra were recorded on a Mass Spectrometer from Waters (Acquity SDS Mass Spectrometer) equipped with an electrospray source (Polarity: Positive and Negative Polarity Switch, Capillary: 3.00 kV, Cone Voltage: 41.00 V, Source temperature: 150° C., Desolvation Gas Flow: 1000 L/Hr, Desolvation temperature: 500° C., Gas Flow @Cone: 50 L/hr, Mass range: 110-800 Da, PDA wavelength range: 210-400 nm. Column: Acquity UPLC HSS T3 C18, length 30 mm, diameter 2.1 mm, particle size 1.8 μm. Column oven temperature 40° C. Solvent gradient: A=Water with 0.1% formic acid: Acetonitrile (95:5 v/v). B=Acetonitrile with 0.05% formic acid. Gradient=0 min 90% A, 10% B; 0.2 min 50% A, 50% B; 0.7-1.3 min 0% A, 100% B; 1.4-1.6 min 90% A, 10% B. Flow rate 0.8 mL/min. Triethylamine (0.145 ml, 1.040 mmol) and 4-(dimethylamino)pyridine (1 mg) were added to a solution of ethyl-imino-methyl-oxo-λ6-sulfane (78.2 mg, 0.693 mmol) in tetrahydrofuran (5 ml) at 0-5° C., followed by dropwise addition of a solution of 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo [4,5-c]pyridin-2-yl]pyridine-3-carbonyl chloride (intermediate 13) (300 mg, 0.693 mmol) in tetrahydrofuran (5 ml). The reaction mixture was stirred at 0-5° C. for 30 minutes. The solvent was removed under reduced pressure and the residue purified by Combiflash over silicagel (0-80% ethyl acetate in cyclohexane) to afford N-(ethyl-methyl-oxo-λ6-sulfanylidene)-5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxamide (compound P8) as a solid, mp 113-114° C. LCMS (method 1): 504 (M+H)+, retention time 0.87 min. To a suspension of 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxamide (intermediate 14) (430 mg, 1.04 mmol) and phosphorus pentoxide (295 mg, 2.08 mmol) in dry chloroform (10 ml) under argon was added a mixture of dimethylsulfoxide (284 mg, 0.26 ml, 3.64 mmol) and triethylamine (111 mg, 152 μl, 1.09 mmol) dropwise while keeping the internal temperature below 35-40° C. The mixture was stirred at room temperature overnight. More of the dimethylsulfoxide (3.64 mmol) and trimethylamine (1.09 mmol) mixture was added and stirring continued at room temperature for 60 hours. The reaction mixture was carefully poured into an ice-cold aqueous NaOH solution while keeping the internal temperature below 10° C. The aqueous phase was extracted several times with chloroform, the combined organic layers washed with water and brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by Combiflash over silicagel (0-10% methanol in ethyl acetate) to afford N-(dimethyl-λ4-sulfanylidene)-5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyrid ine-3-carboxamide (compound P5) as a solid. LCMS (method 1): 474 (M+H)+, retention time 0.79 min. A solution of 5-ethylsulfonyl-6-[6-(trifluoro-methyl)pyrazolo[4,3-c]pyridin-2-yl]pyridine-3-carboxylic acid (intermediate 115) (110 mg, 0.27 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI, 59 mg, 0.30 mmol) and imino-dimethyl-oxo-A6-sulfane (30 mg, 0.30 mmol) in pyridine (2 ml) was stirred at 80° C. for 3 hours. The reaction mixture was poured into water and extracted with ethyl acetate, the combined extracts washed with brine, dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by Combiflash over silicagel (ethyl acetate/hexane 9:1) to afford N-[dimethyl(oxo)-λ6-sulfanylidene]-5-ethylsulfonyl-6-[6-(trifluoromethyl) pyrazolo[4,3-c]pyridin-2-yl]pyridine-3-carboxamide (compound P24) as a solid, mp 268-270° C. LCMS (method 3): 476 (M+H)+, retention time 1.41 min.1H NMR (400 MHz, DMSO-d6) δ ppm 1.29 (t, J=7.30 Hz, 3H), 3.58 (s, 6H), 4.00 (q, J=7.30 Hz, 2H), 8.40 (s, 1H), 8.97 (d, J=1.96 Hz, 1H), 9.39 (d, J=1.96 Hz, 1H), 9.52 (m, 2H). A high pressure reactor under argon was charged with a degassed solution of 2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-3-methyl-6-(trifluoro-methyl)imidazo[4,5-c]pyridine (WO16/005263) (10.0 g, 22.26 mmol) in methanol (111 ml). Triethylamine (2.7 g, 3.44 ml, 26.71 mmol) and dichloro[1,3-bis(diphenylphosphino)propane]palladium(II) (PdCl2(dippp)), 0.66 g, 1.11 mmol) were added. The reaction vessel was pressurized with 5 bar carbon monoxide and heated to 100° C. for 24 hours. After cooling, the mixture was filtered over Celite and the filtrate concentrated. The residue was suspended in ethyl acetate, the solid isolated by filtration and washed with water. This solid material was dissolved in dichloromethane, the solution dried over sodium sulfate, filtrated and concentrated to afford crude 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyrid ine-3-carboxylate (intermediate II) as a solid, mp 200-202° C. This material was used without further purification. LCMS (method 1): 429 (M+H)+, retention time 0.94 min. To a solution of methyl 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl] pyridine-3-carboxylate (5 g, 11.67 mmol) in a 3:1-mixture of tetrahydrofuran and water (134 ml) at 0-5° C. was added lithium hydroxide monohydrate (514 mg, 12.25 mmol). The reaction mixture was stirred at room temperature overnight, then diluted with tert-butyl methyl ether. The phases were separated, the water layer acidified to pH 2 with aqueous hydrochloric acid and the resulting suspension isolated by filtration. This solid residue was dissolved in dichloromethane, the solution dried over sodium sulfate, filtrated and concentrated to afford crude 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxylic acid (intermediate 12) as a solid, mp 313-314° C. This material was used without further purification. LCMS (method 1): 415 (M+H)+ and 413 (M−H)−, retention time 0.78 min. To a solution of 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxylic acid (3.0 g, 7.2 mmol) in dichloromethane (80 ml) at 0-5° C. was added oxalyl chloride (0.76 ml, 8.7 mmol) and the mixture was stirred at room temperature overnight. The reaction mixture was concentrated to dryness to afford crude 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carbonyl chloride (intermediate 13) as a solid. This material was used without further purification.1H NMR (400 MHz, d6-acetone) δ ppm 1.34 (t, 3H), 3.96 (q, 2H), 4.08 (s, 3H), 8.23 (s, 1H), 9.08 (d, J=2.0 Hz, 1H), 9.28 (s, 1H), 9.69 (d, J=2.0 Hz, 1H). Triethylamine (0.725 ml, 5.2 mmol) and 4-(dimethylamino)pyridine (4 mg) were added to a 0.5M solution of ammonia in dioxane (69 ml, 34.5 mmol) at 0-5° C., followed by dropwise addition of a solution of 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo [4,5-c]pyridin-2-yl]pyridine-3-carbonyl chloride (intermediate 13) (1.5 g, 3.47 mmol) in tetrahydrofuran (6 ml). The reaction mixture was stirred at 0-5° C. for 30 minutes, then concentrated to dryness under reduced pressure to afford crude 5-ethyl-sulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxamide (intermediate 14) as a solid, mp 251-252° C. LCMS (method 1): 414 (M+H)+, retention time 0.76 min. To a solution of methyl 3-ethylsulfonyl-4-[7-(trifluoromethyl)imidazo[1,2-c]pyrimidin-2-yl]benzoate (intermediate 112) (800 mg, 1.94 mmol) in dry N,N-dimethylformamide (15 ml) was added dry lithium chloride LiCl (410 mg, 9.68 mmol) and the mixture was heated in the microwave at 150° C. for one hour. Repeatedly more LiCl (14×82 mg) was added, whereby heating at 150° C. for one hour was continued after each addition. The reaction mixture was diluted with water and ethyl acetate, the phases were separated, the water layer acidified to pH 4-5 with 0.1N aqueous hydrochloric acid and the product extensively extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtrated and concentrated to afford crude 3-ethylsulfonyl-4[7-(trifluoromethyl) imidazo[1,2-c]pyrimidin-2-yl]benzoic acid (intermediate 113) as a solid. This material was further dried in vacuo over phosphorus pentoxide at 40° C. overnight and used without further purification. LCMS (method 1): 400 (M+H)+ and 398 (M−H)−, retention time 0.82 min. To a solution of 6-(5-bromo-3-ethylsulfonyl-2-pyridyl)-7-methyl-3-(trifluoromethyl)imidazo[4,5-c]pyridazine (WO16/059145) (900 mg, 2.0 mmol) in 1-methyl-2-pyrrolidone (11 ml) was added copper(I) cyanide (716 mg, 8.0 mmol) and the reaction mixture was purged with argon. Copper(I) iodide (38 mg, 0.20 mmol) was added and the mixture heated in the microwave at 150° C. for one hour. The reaction mixture was poured into iced water, the resulting suspension filtered, and the solid washed with cold water. The solid residue was treated with tetrahydrofuran, the solution filtered and the filtrate concentrated to dryness under reduced pressure and this processing repeated with toluene three times. The crude solid was further stirred in cold ethyl acetate, the suspension filtered and the solid dried under vacuum at 50° C. overnight to afford 5-ethylsulfonyl-6-[7-methyl-3-(trifluoromethyl) imidazo[4,5-c]pyridazin-6-yl]pyridine-3-carbonitrile (intermediate 19). This material was used without further purification.1H NMR (400 MHz, CDCl3) δ ppm 1.45 (t, J=7.3 Hz, 3H), 3.91 (q, J=7.3 Hz, 2H), 4.15 (s, 3H), 8.25 (s, 1H), 8.85 (d, J=1.8 Hz, 1H), 9.29 (d, J=1.8 Hz, 1H). LCMS (method 1): 397 (M+H)+, retention time 0.87 min. A solution of 5-ethylsulfonyl-6-[7-methyl-3-(trifluoromethyl)imidazo[4,5-c]pyridazin-6-yl]pyridine-3-carbonitrile (2.7 g, 6.8 mmol) in 50% aqueous sulfuric acid (40 ml) was heated at 100° C. for 2 hours. The reaction mixture was diluted with iced water, the resulting solid filtered, washed with cold water, and dried in vacuo over phosphorus pentoxide at 50° C. overnight to afford 5-ethylsulfonyl-6-[7-methyl-3-(trifluoromethyl)imidazo[4,5-c]pyridazin-6-yl]pyridine-3-carboxylic acid (intermediate 110). LCMS (method 1): 416 (M+H)+ and 414 (M−H)−, retention time 0.76 min. To a solution of 2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-6-(trifluoromethyl)pyrazolo[4,3-c]pyridine (WO16/020286) (970 mg, 2.23 mmol) in dry toluene (10 ml) was added tributyl(vinyl)tin (1.09 g, 97%, 3.34 mmol) and the reaction mixture was purged with argon for 15 minutes. Palladium(0) tetrakis (triphenylphosphine) (129 mg, 0.111 mmol) was added and the mixture heated at 110° C. for two hours. The reaction mixture was poured into water (50 ml) and extracted with ethyl acetate (3×30 ml). The combined extracts were washed with brine, dried over sodium sulfate and evaporated under reduced pressure. The residue was purified by Combiflash over silicagel (ethyl acetate/hexane 1:1) to afford 2-(3-ethylsulfonyl-5-vinyl-2-pyridyl)-6-(trifluoromethyl)pyrazolo[4,3-c]pyridine. LCMS (method 4): 383 (M+H)+, retention time 1.02 min. To a solution of 2-(3-ethylsulfonyl-5-vinyl-2-pyridyl)-6-(trifluoromethyl)pyrazolo[4,3-c]pyridine (100 mg, 0.26 mmol) in 1,4-dioxane at 0° C. were added potassium osmate(VI) dihydrate (48 mg, 0.13 mmol; CAUTION!), followed by a solution of sodium periodate (117 mg, 0.55 mmol) in water (2 ml). The reaction mixture was stirred at room temperature for 3 hours. Additional sodium periodate (0.26 mmol) was added and the mixture further stirred at room temperature for 2 hours. The reaction mixture was poured into water (20 ml) and acidified using 2N aqueous hydrochloric acid. The product was extracted with ethyl acetate (3×20 ml), the combined extracts washed with brine, dried over sodium sulfate and evaporated under reduced pressure to afford crude 5-ethylsulfonyl-6-[6-(trifluoro-methyl)pyrazolo[4,3-c]pyridin-2-yl] pyridine-3-carboxylic acid (intermediate 115) as a solid. This material was used without further purification.1H NMR (400 MHz, DMSO-d6) δ ppm 1.31 (t, 3H), 4.03 (q, 2H), 8.41 (s, 1H), 8.93 (d, 1H), 9.39 (d, 1H), 9.53 (m, 2H), 10.32 (s, 1H). LCMS (method 3): 401 (M+H)+ and 399 (M−H)−, retention time 1.32 min. The activity of the compositions according to the invention can be broadened considerably, and adapted to prevailing circumstances, by adding other insecticidally, acaricidally and/or fungicidally active ingredients. The mixtures of the compounds of formula I with other insecticidally, acaricidally and/or fungicidally active ingredients may also have further surprising advantages which can also be described, in a wider sense, as synergistic activity. For example, better tolerance by plants, reduced phytotoxicity, insects can be controlled in their different development stages or better behaviour during their production, for example during grinding or mixing, during their storage or during their use. Suitable additions to active ingredients here are, for example, representatives of the following classes of active ingredients: organophosphorus compounds, nitrophenol derivatives, thioureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridylmethyleneamino derivatives, macrolides, neonicotinoids and The following mixtures of the compounds of formula I with active ingredients are preferred (the abbreviation “TX” means “one compound selected from the group consisting of the compounds described in Tables 1 to 12 and Table P of the present invention”): an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628)+TX, an acaricide selected from the group of substances consisting of 1,1-bis(4-chlorophenyl)-2-ethoxyethanol (IUPAC name) (910)+TX, 2,4-dichlorophenyl benzenesulfonate (IUPAC/Chemical Abstracts name) (1059)+TX, 2-fluoro-N-methyl-N-1-naphthylacetamide (IUPAC name) (1295)+TX, 4-chlorophenyl phenyl sulfone (IUPAC name) (981)+TX, abamectin (1)+TX, acequinocyl (3)+TX, acetoprole+TX, acrinathrin (9)+TX, aldicarb (16)+TX, aldoxycarb (863)+TX, alpha-cypermethrin (202)+TX, amidithion (870)+TX, amidoflumet+TX, amidothioate (872)+TX, amiton (875)+TX, amiton hydrogen oxalate (875)+TX, amitraz (24)+TX, aramite (881)+TX, arsenous oxide (882)+TX, AVI 382 (compound code)+TX, AZ 60541 (compound code)+TX, azinphos-ethyl (44)+TX, azinphos-methyl (45)+TX, azobenzene (IUPAC name) (888)+TX, azocyclotin (46)+TX, azothoate (889)+TX, benomyl (62)+TX, benoxafos (alternative name)+TX, benzoximate (71)+TX, benzyl benzoate (IUPAC name)+TX, bifenazate (74)+TX, bifenthrin (76)+TX, binapacryl (907)+TX, brofenvalerate (alternative name)+TX, bromocyclen (918)+TX, bromophos (920)+TX, bromophos-ethyl (921)+TX, bromopropylate (94)+TX, buprofezin (99)+TX, butocarboxim (103)+TX, butoxycarboxim (104)+TX, butylpyridaben (alternative name)+TX, calcium polysulfide (IUPAC name) (111)+TX, camphechlor (941)+TX, carbanolate (943)+TX, carbaryl (115)+TX, carbofuran (118)+TX, carbophenothion (947)+TX, CGA 50′439 (development code) (125)+TX, chinomethionat (126)+TX, chlorbenside (959)+TX, chlordimeform (964)+TX, chlordimeform hydrochloride (964)+TX, chlorfenapyr (130)+TX, chlorfenethol (968)+TX, chlorfenson (970)+TX, chlorfensulfide (971)+TX, chlorfenvinphos (131)+TX, chlorobenzilate (975)+TX, chloromebuform (977)+TX, chloromethiuron (978)+TX, chloropropylate (983)+TX, chlorpyrifos (145)+TX, chlorpyrifos-methyl (146)+TX, chlorthiophos (994)+TX, cinerin I (696)+TX, cinerin II (696)+TX, cinerins (696)+TX, clofentezine (158)+TX, closantel (alternative name)+TX, coumaphos (174)+TX, crotamiton (alternative name)+TX, crotoxyphos (1010)+TX, cufraneb (1013)+TX, cyanthoate (1020)+TX, cyflumetofen (CAS Reg. No.: 400882-07-7)+TX, cyhalothrin (196)+TX, cyhexatin (199)+TX, cypermethrin (201)+TX, DCPM (1032)+TX, DDT (219)+TX, demephion (1037)+TX, demephion-O (1037)+TX, demephion-S (1037)+TX, demeton (1038)+TX, demeton-methyl (224)+TX, demeton-O (1038)+TX, demeton-O-methyl (224)+TX, demeton-S (1038)+TX, demeton-S-methyl (224)+TX, demeton-S-methylsulfon (1039)+TX, diafenthiuron (226)+TX, dialifos (1042)+TX, diazinon (227)+TX, dichlofluanid (230)+TX, dichlorvos (236)+TX, dicliphos (alternative name)+TX, dicofol (242)+TX, dicrotophos (243)+TX, dienochlor (1071)+TX, dimefox (1081)+TX, dimethoate (262)+TX, dinactin (alternative name) (653)+TX, dinex (1089)+TX, dinex-diclexine (1089)+TX, dinobuton (269)+TX, dinocap (270)+TX, dinocap-4+TX, dinocap-6+TX, dinocton (1090)+TX, dinopenton (1092)+TX, dinosulfon (1097)+TX, dinoterbon (1098)+TX, dioxathion (1102)+TX, diphenyl sulfone (IUPAC name) (1103)+TX, disulfiram (alternative name)+TX, disulfoton (278)+TX, DNOC (282)+TX, dofenapyn (1113)+TX, doramectin (alternative name)+TX, endosulfan (294)+TX, endothion (1121)+TX, EPN (297)+TX, eprinomectin (alternative name)+TX, ethion (309)+TX, ethoate-methyl (1134)+TX, etoxazole (320)+TX, etrimfos (1142)+TX, fenazaflor (1147)+TX, fenazaquin (328)+TX, fenbutatin oxide (330)+TX, fenothiocarb (337)+TX, fenpropathrin (342)+TX, fenpyrad (alternative name)+TX, fenpyroximate (345)+TX, fenson (1157)+TX, fentrifanil (1161)+TX, fenvalerate (349)+TX, fipronil (354)+TX, fluacrypyrim (360)+TX, fluazuron (1166)+TX, flubenzimine (1167)+TX, flucycloxuron (366)+TX, flucythrinate (367)+TX, fluenetil (1169)+TX, flufenoxuron (370)+TX, flumethrin (372)+TX, fluorbenside (1174)+TX, fluvalinate (1184)+TX, FMC 1137 (development code) (1185)+TX, formetanate (405)+TX, formetanate hydrochloride (405)+TX, formothion (1192)+TX, formparanate (1193)+TX, gamma-HCH (430)+TX, glyodin (1205)+TX, halfenprox (424)+TX, heptenophos (432)+TX, hexadecyl cyclopropanecarboxylate (IUPAC/Chemical Abstracts name) (1216)+TX, hexythiazox (441)+TX, iodomethane (IUPAC name) (542)+TX, isocarbophos (alternative name) (473)+TX, isopropyl O-(methoxyaminothiophosphoryl)salicylate (IUPAC name) (473)+TX, ivermectin (alternative name)+TX, jasmolin I (696)+TX, jasmolin II (696)+TX, jodfenphos (1248)+TX, lindane (430)+TX, lufenuron (490)+TX, malathion (492)+TX, malonoben (1254)+TX, mecarbam (502)+TX, mephosfolan (1261)+TX, mesulfen (alternative name)+TX, methacrifos (1266)+TX, methamidophos (527)+TX, methidathion (529)+TX, methiocarb (530)+TX, methomyl (531)+TX, methyl bromide (537)+TX, metolcarb (550)+TX, mevinphos (556)+TX, mexacarbate (1290)+TX, milbemectin (557)+TX, milbemycin oxime (alternative name)+TX, mipafox (1293)+TX, monocrotophos (561)+TX, morphothion (1300)+TX, moxidectin (alternative name)+TX, naled (567)+TX, NC-184 (compound code)+TX, NC-512 (compound code)+TX, nifluridide (1309)+TX, nikkomycins (alternative name)+TX, nitrilacarb (1313)+TX, nitrilacarb 1:1 zinc chloride complex (1313)+TX, NNI-0101 (compound code)+TX, NNI-0250 (compound code)+TX, omethoate (594)+TX, oxamyl (602)+TX, oxydeprofos (1324)+TX, oxydisulfoton (1325)+TX, pp′-DDT (219)+TX, parathion (615)+TX, permethrin (626)+TX, petroleum oils (alternative name) (628)+TX, phenkapton (1330)+TX, phenthoate (631)+TX, phorate (636)+TX, phosalone (637)+TX, phosfolan (1338)+TX, phosmet (638)+TX, phosphamidon (639)+TX, phoxim (642)+TX, pirimiphos-methyl (652)+TX, polychloroterpenes (traditional name) (1347)+TX, polynactins (alternative name) (653)+TX, proclonol (1350)+TX, profenofos (662)+TX, promacyl (1354)+TX, propargite (671)+TX, propetamphos (673)+TX, propoxur (678)+TX, prothidathion (1360)+TX, prothoate (1362)+TX, pyrethrin I (696)+TX, pyrethrin II (696)+TX, pyrethrins (696)+TX, pyridaben (699)+TX, pyridaphenthion (701)+TX, pyrimidifen (706)+TX, pyrimitate (1370)+TX, quinalphos (711)+TX, quintiofos (1381)+TX, R-1492 (development code) (1382)+TX, RA-17 (development code) (1383)+TX, rotenone (722)+TX, schradan (1389)+TX, sebufos (alternative name)+TX, selamectin (alternative name)+TX, SI-0009 (compound code)+TX, sophamide (1402)+TX, spirodiclofen (738)+TX, spiromesifen (739)+TX, SSI-121 (development code) (1404)+TX, sulfiram (alternative name)+TX, sulfluramid (750)+TX, sulfotep (753)+TX, sulfur (754)+TX, SZI-121 (development code) (757)+TX, tau-fluvalinate (398)+TX, tebufenpyrad (763)+TX, TEPP (1417)+TX, terbam (alternative name)+TX, tetrachlorvinphos (777)+TX, tetradifon (786)+TX, tetranactin (alternative name) (653)+TX, tetrasul (1425)+TX, thiafenox (alternative name)+TX, thiocarboxime (1431)+TX, thiofanox (800)+TX, thiometon (801)+TX, thioquinox (1436)+TX, thuringiensin (alternative name)+TX, triamiphos (1441)+TX, triarathene (1443)+TX, triazophos (820)+TX, triazuron (alternative name)+TX, trichlorfon (824)+TX, trifenofos (1455)+TX, trinactin (alternative name) (653)+TX, vamidothion (847)+TX, vaniliprole and YI-5302 (compound code)+TX, an algicide selected from the group of substances consisting of bethoxazin+TX, copper dioctanoate (IUPAC name) (170)+TX, copper sulfate (172)+TX, cybutryne+TX, dichlone (1052)+TX, dichlorophen (232)+TX, endothal (295)+TX, fentin (347)+TX, hydrated lime+TX, nabam (566)+TX, quinoclamine (714)+TX, quinonamid (1379)+TX, simazine (730)+TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347)+TX, an anthelmintic selected from the group of substances consisting of abamectin (1)+TX, crufomate (1011)+TX, doramectin (alternative name)+TX, emamectin (291)+TX, emamectin benzoate (291)+TX, eprinomectin (alternative name)+TX, ivermectin (alternative name)+TX, milbemycin oxime (alternative name)+TX, moxidectin (alternative name)+TX, piperazine+TX, selamectin (alternative name)+TX, spinosad (737) and thiophanate (1435)+TX, an avicide selected from the group of substances consisting of chloralose (127)+TX, endrin (1122)+TX, fenthion (346)+TX, pyridin-4-amine (IUPAC name) (23) and strychnine (745)+TX, a bactericide selected from the group of substances consisting of 1-hydroxy-1H-pyridine-2-thione (IUPAC name) (1222)+TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748)+TX, 8-hydroxyquinoline sulfate (446)+TX, bronopol (97)+TX, copper dioctanoate (IUPAC name) (170)+TX, copper hydroxide (IUPAC name) (169)+TX, cresol+TX, dichlorophen (232)+TX, dipyrithione (1105)+TX, dodicin (1112)+TX, fenaminosulf (1144)+TX, formaldehyde (404)+TX, hydrargaphen (alternative name)+TX, kasugamycin (483)+TX, kasugamycin hydrochloride hydrate (483)+TX, nickel bis(dimethyldithiocarbamate) (IUPAC name) (1308)+TX, nitrapyrin (580)+TX, octhilinone (590)+TX, oxolinic acid (606)+TX, oxytetracycline (611)+TX, potassium hydroxyquinoline sulfate (446)+TX, probenazole (658)+TX, streptomycin (744)+TX, streptomycin sesquisulfate (744)+TX, tecloftalam (766)+TX, and thiomersal (alternative name)+TX, a biological agent selected from the group of substances consisting of a soil sterilant selected from the group of substances consisting of iodomethane (IUPAC name) (542) and methyl bromide (537)+TX, a chemosterilant selected from the group of substances consisting of apholate+TX, bisazir (alternative name)+TX, busulfan (alternative name)+TX, diflubenzuron (250)+TX, dimatif (alternative name)+TX, hemel+TX, hempa+TX, metepa+TX, methiotepa+TX, methyl apholate+TX, morzid+TX, penfluron (alternative name)+TX, tepa+TX, thiohempa (alternative name)+TX, thiotepa (alternative name)+TX, tretamine (alternative name) and uredepa (alternative name)+TX, an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (IUPAC name) (222)+TX, (E)-tridec-4-en-1-yl acetate (IUPAC name) (829)+TX, (E)-6-methylhept-2-en-4-ol (IUPAC name) (541)+TX, (E,Z)-tetradeca-4,10-dien-1-yl acetate (IUPAC name) (779)+TX, (Z)-dodec-7-en-1-yl acetate (IUPAC name) (285)+TX, (Z)-hexadec-11-enal (IUPAC name) (436)+TX, (Z)-hexadec-11-en-1-yl acetate (IUPAC name) (437)+TX, (Z)-hexadec-13-en-11-yn-1-yl acetate (IUPAC name) (438)+TX, (Z)-icos-13-en-10-one (IUPAC name) (448)+TX, (Z)-tetradec-7-en-1-al (IUPAC name) (782)+TX, (Z)-tetradec-9-en-1-ol (IUPAC name) (783)+TX, (Z)-tetradec-9-en-1-yl acetate (IUPAC name) (784)+TX, (7E,9Z)-dodeca-7,9-dien-1-yl acetate (IUPAC name) (283)+TX, (9Z,11E)-tetradeca-9,11-dien-1-yl acetate (IUPAC name) (780)+TX, (9Z,12E)-tetradeca-9,12-dien-1-yl acetate (IUPAC name) (781)+TX, 14-methyloctadec-1-ene (IUPAC name) (545)+TX, 4-methylnonan-5-ol with 4-methylnonan-5-one (IUPAC name) (544)+TX, alpha-multistriatin (alternative name)+TX, brevicomin (alternative name)+TX, codlelure (alternative name)+TX, codlemone (alternative name) (167)+TX, cuelure (alternative name) (179)+TX, disparlure (277)+TX, dodec-8-en-1-yl acetate (IUPAC name) (286)+TX, dodec-9-en-1-yl acetate (IUPAC name) (287)+TX, dodeca-8+TX, 10-dien-1-yl acetate (IUPAC name) (284)+TX, dominicalure (alternative name)+TX, ethyl 4-methyloctanoate (IUPAC name) (317)+TX, eugenol (alternative name)+TX, frontalin (alternative name)+TX, gossyplure (alternative name) (420)+TX, grandlure (421)+TX, grandlure I (alternative name) (421)+TX, grandlure II (alternative name) (421)+TX, grandlure III (alternative name) (421)+TX, grandlure IV (alternative name) (421)+TX, hexalure+TX, ipsdienol (alternative name)+TX, ipsenol (alternative name)+TX, japonilure (alternative name) (481)+TX, lineatin (alternative name)+TX, litlure (alternative name)+TX, looplure (alternative name)+TX, medlure+TX, megatomoic acid (alternative name)+TX, methyl eugenol (alternative name) (540)+TX, muscalure (563)+TX, octadeca-2,13-dien-1-yl acetate (IUPAC name) (588)+TX, octadeca-3,13-dien-1-yl acetate (IUPAC name) (589)+TX, orfralure (alternative name)+TX, oryctalure (alternative name) (317)+TX, ostramone (alternative name)+TX, siglure+TX, sordidin (alternative name) (736)+TX, sulcatol (alternative name)+TX, tetradec-11-en-1-yl acetate (IUPAC name) (785)+TX, trimedlure (839)+TX, trimedlure A (alternative name) (839)+TX, trimedlure B1 (alternative name) (839)+TX, trimedlure B2 (alternative name) (839)+TX, trimedlure C (alternative name) (839) and trunc-call (alternative name)+TX, an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (IUPAC name) (591)+TX, butopyronoxyl (933)+TX, butoxy(polypropylene glycol) (936)+TX, dibutyl adipate (IUPAC name) (1046)+TX, dibutyl phthalate (1047)+TX, dibutyl succinate (IUPAC name) (1048)+TX, diethyltoluamide+TX, dimethyl carbate+TX, dimethyl phthalate+TX, ethyl hexanediol (1137)+TX, hexamide+TX, methoquin-butyl (1276)+TX, methylneodecanamide+TX, oxamate and picaridin+TX, an insecticide selected from the group of substances consisting of 1-dichloro-1-nitroethane (IUPAC/Chemical Abstracts name) (1058)+TX, 1,1-dichloro-2,2-bis(4-ethylphenyl)ethane (IUPAC name) (1056), +TX, 1,2-dichloropropane (IUPAC/Chemical Abstracts name) (1062)+TX, 1,2-dichloropropane with 1,3-dichloropropene (IUPAC name) (1063)+TX, 1-bromo-2-chloroethane (IUPAC/Chemical Abstracts name) (916)+TX, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate (IUPAC name) (1451)+TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate (IUPAC name) (1066)+TX, 2-(1,3-dithiolan-2-yl)phenyl dimethylcarbamate (IUPAC/Chemical Abstracts name) (1109)+TX, 2-(2-butoxyethoxy)ethyl thiocyanate (IUPAC/Chemical Abstracts name) (935)+TX, 2-(4,5-dimethyl-1,3-dioxolan-2-yl)phenyl methylcarbamate (IUPAC/Chemical Abstracts name) (1084)+TX, 2-(4-chloro-3,5-xylyloxy)ethanol (IUPAC name) (986)+TX, 2-chlorovinyl diethyl phosphate (IUPAC name) (984)+TX, 2-imidazolidone (IUPAC name) (1225)+TX, 2-isovalerylindan-1,3-dione (IUPAC name) (1246)+TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate (IUPAC name) (1284)+TX, 2-thiocyanatoethyl laurate (IUPAC name) (1433)+TX, 3-bromo-1-chloroprop-1-ene (IUPAC name) (917)+TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate (IUPAC name) (1283)+TX, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (IUPAC name) (1285)+TX, 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate (IUPAC name) (1085)+TX, abamectin (1)+TX, acephate (2)+TX, acetamiprid (4)+TX, acethion (alternative name)+TX, acetoprole+TX, acrinathrin (9)+TX, acrylonitrile (IUPAC name) (861)+TX, alanycarb (15)+TX, aldicarb (16)+TX, aldoxycarb (863)+TX, aldrin (864)+TX, allethrin (17)+TX, allosamidin (alternative name)+TX, allyxycarb (866)+TX, alpha-cypermethrin (202)+TX, alpha-ecdysone (alternative name)+TX, aluminium phosphide (640)+TX, amidithion (870)+TX, amidothioate (872)+TX, aminocarb (873)+TX, amiton (875)+TX, amiton hydrogen oxalate (875)+TX, amitraz (24)+TX, anabasine (877)+TX, athidathion (883)+TX, AVI 382 (compound code)+TX, AZ 60541 (compound code)+TX, azadirachtin (alternative name) (41)+TX, azamethiphos (42)+TX, azinphos-ethyl (44)+TX, azinphos-methyl (45)+TX, azothoate (889)+TX, a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (IUPAC name) (913)+TX, bromoacetamide+TX, calcium arsenate+TX, cloethocarb (999)+TX, copper acetoarsenite+TX, copper sulfate (172)+TX, fentin (347)+TX, ferric phosphate (IUPAC name) (352)+TX, metaldehyde (518)+TX, methiocarb (530)+TX, niclosamide (576)+TX, niclosamide-olamine (576)+TX, pentachlorophenol (623)+TX, sodium pentachlorophenoxide (623)+TX, tazimcarb (1412)+TX, thiodicarb (799)+TX, tributyltin oxide (913)+TX, trifenmorph (1454)+TX, trimethacarb (840)+TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347)+TX, pyriprole [394730-71-3]+TX, a nematicide selected from the group of substances consisting of AKD-3088 (compound code)+TX, 1,2-dibromo-3-chloropropane (IUPAC/Chemical Abstracts name) (1045)+TX, 1,2-dichloropropane (IUPAC/Chemical Abstracts name) (1062)+TX, 1,2-dichloropropane with 1,3-dichloropropene (IUPAC name) (1063)+TX, 1,3-dichloropropene (233)+TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide (IUPAC/Chemical Abstracts name) (1065)+TX, 3-(4-chlorophenyl)-5-methylrhodanine (IUPAC name) (980)+TX, 5-methyl-6-thioxo-1,3,5-thiadiazinan-3-ylacetic acid (IUPAC name) (1286)+TX, 6-isopentenylaminopurine (alternative name) (210)+TX, abamectin (1)+TX, acetoprole+TX, alanycarb (15)+TX, aldicarb (16)+TX, aldoxycarb (863)+TX, AZ 60541 (compound code)+TX, benclothiaz+TX, benomyl (62)+TX, butylpyridaben (alternative name)+TX, cadusafos (109)+TX, carbofuran (118)+TX, carbon disulfide (945)+TX, carbosulfan (119)+TX, chloropicrin (141)+TX, chlorpyrifos (145)+TX, cloethocarb (999)+TX, cytokinins (alternative name) (210)+TX, dazomet (216)+TX, DBCP (1045)+TX, DCIP (218)+TX, diamidafos (1044)+TX, dichlofenthion (1051)+TX, dicliphos (alternative name)+TX, dimethoate (262)+TX, doramectin (alternative name)+TX, emamectin (291)+TX, emamectin benzoate (291)+TX, eprinomectin (alternative name)+TX, ethoprophos (312)+TX, ethylene dibromide (316)+TX, fenamiphos (326)+TX, fenpyrad (alternative name)+TX, fensulfothion (1158)+TX, fosthiazate (408)+TX, fosthietan (1196)+TX, furfural (alternative name)+TX, GY-81 (development code) (423)+TX, heterophos+TX, iodomethane (IUPAC name) (542)+TX, isamidofos (1230)+TX, isazofos (1231)+TX, ivermectin (alternative name)+TX, kinetin (alternative name) (210)+TX, mecarphon (1258)+TX, metam (519)+TX, metam-potassium (alternative name) (519)+TX, metam-sodium (519)+TX, methyl bromide (537)+TX, methyl isothiocyanate (543)+TX, milbemycin oxime (alternative name)+TX, moxidectin (alternative name)+TX, a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate and nitrapyrin (580)+TX, a plant activator selected from the group of substances consisting of acibenzolar (6)+TX, acibenzolar-S-methyl (6)+TX, probenazole (658) and a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1,3-dione (IUPAC name) (1246)+TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748)+TX, alpha-chlorohydrin+TX, aluminium phosphide (640)+TX, antu (880)+TX, arsenous oxide (882)+TX, barium carbonate (891)+TX, bisthiosemi (912)+TX, brodifacoum (89)+TX, bromadiolone (91)+TX, bromethalin (92)+TX, calcium cyanide (444)+TX, chloralose (127)+TX, chlorophacinone (140)+TX, cholecalciferol (alternative name) (850)+TX, coumachlor (1004)+TX, coumafuryl (1005)+TX, coumatetralyl (175)+TX, crimidine (1009)+TX, difenacoum (246)+TX, difethialone (249)+TX, diphacinone (273)+TX, ergocalciferol (301)+TX, flocoumafen (357)+TX, fluoroacetamide (379)+TX, flupropadine (1183)+TX, flupropadine hydrochloride (1183)+TX, gamma-HCH (430)+TX, HCH (430)+TX, hydrogen cyanide (444)+TX, iodomethane (IUPAC name) (542)+TX, lindane (430)+TX, magnesium phosphide (IUPAC name) (640)+TX, methyl bromide (537)+TX, norbormide (1318)+TX, phosacetim (1336)+TX, phosphine (IUPAC name) (640)+TX, phosphorus+TX, pindone (1341)+TX, potassium arsenite+TX, pyrinuron (1371)+TX, scilliroside (1390)+TX, sodium arsenite+TX, sodium cyanide (444)+TX, sodium fluoroacetate (735)+TX, strychnine (745)+TX, thallium sulfate+TX, warfarin (851) and zinc phosphide (640)+TX, a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (IUPAC name) (934)+TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (IUPAC name) (903)+TX, farnesol with nerolidol (alternative name) (324)+TX, MB-599 (development code) (498)+TX, MGK 264 (development code) (296)+TX, piperonyl butoxide (649)+TX, piprotal (1343)+TX, propyl isomer (1358)+TX, S421 (development code) (724)+TX, sesamex (1393)+TX, sesasmolin (1394) and sulfoxide (1406)+TX, an animal repellent selected from the group of substances consisting of anthraquinone (32)+TX, chloralose (127)+TX, copper naphthenate+TX, copper oxychloride (171)+TX, diazinon (227)+TX, dicyclopentadiene (chemical name) (1069)+TX, guazatine (422)+TX, guazatine acetates (422)+TX, methiocarb (530)+TX, pyridin-4-amine (IUPAC name) (23)+TX, thiram (804)+TX, trimethacarb (840)+TX, zinc naphthenate and ziram (856)+TX, a virucide selected from the group of substances consisting of imanin (alternative name) and ribavirin (alternative name)+TX, a wound protectant selected from the group of substances consisting of mercuric oxide (512)+TX, octhilinone (590) and thiophanate-methyl (802)+TX, and biologically active compounds selected from the group consisting of azaconazole (60207-31-0]+TX, bitertanol [70585-36-3]+TX, bromuconazole [116255-48-2]+TX, cyproconazole [94361-06-5]+TX, difenoconazole [119446-68-3]+TX, diniconazole [83657-24-3]+TX, epoxiconazole [106325-08-0]+TX, fenbuconazole [114369-43-6]+TX, fluquinconazole [136426-54-5]+TX, flusilazole [85509-19-9]+TX, flutriafol [76674-21-0]+TX, hexaconazole [79983-71-4]+TX, imazalil [35554-44-0]+TX, imibenconazole [86598-92-7]+TX, ipconazole [125225-28-7]+TX, metconazole [125116-23-6]+TX, myclobutanil [88671-89-0]+TX, pefurazoate [101903-30-4]+TX, penconazole [66246-88-6]+TX, prothioconazole [178928-70-6]+TX, pyrifenox [88283-41-4]+TX, prochloraz [67747-09-5]+TX, propiconazole [60207-90-1]+TX, simeconazole [149508-90-7]+TX, tebuconazole [107534-96-3]+TX, tetraconazole [112281-77-3]+TX, triadimefon [43121-43-3]+TX, triadimenol [55219-65-3]+TX, triflumizole [99387-89-0]+TX, triticonazole [131983-72-7]+TX, ancymidol [12771-68-5]+TX, fenarimol [60168-88-9]+TX, nuarimol [63284-71-9]+TX, bupirimate [41483-43-6]+TX, dimethirimol [5221-53-4]+TX, ethirimol [23947-60-6]+TX, dodemorph [1593-77-7]+TX, fenpropidine [67306-00-7]+TX, fenpropimorph [67564-91-4]+TX, spiroxamine [118134-30-8]+TX, tridemorph [81412-43-3]+TX, cyprodinil [121552-61-2]+TX, mepanipyrim [110235-47-7]+TX, pyrimethanil [53112-28-0]+TX, fenpiclonil [74738-17-3]+TX, fludioxonil [131341-86-1]+TX, benalaxyl [71626-11-4]+TX, furalaxyl [57646-30-7]+TX, metalaxyl [57837-19-1]+TX, R-metalaxyl [70630-17-0]+TX, ofurace [58810-48-3]+TX, oxadixyl [77732-09-3]+TX, benomyl [17804-35-2]+TX, carbendazim [10605-21-7]+TX, debacarb [62732-91-6]+TX, fuberidazole [3878-19-1]+TX, thiabendazole [148-79-8]+TX, chlozolinate [84332-86-5]+TX, dichlozoline [24201-58-9]+TX, iprodione [36734-19-7]+TX, myclozoline [54864-61-8]+TX, procymidone [32809-16-8]+TX, vinclozoline [50471-44-8]+TX, boscalid [188425-85-6]+TX, carboxin [5234-68-4]+TX, fenfuram [24691-80-3]+TX, flutolanil [66332-96-5]+TX, mepronil [55814-41-0]+TX, oxycarboxin [5259-88-1]+TX, penthiopyrad [183675-82-3]+TX, thifluzamide [130000-40-7]+TX, guazatine [108173-90-6]+TX, dodine [2439-10-3] [112-65-2] (free base)+TX, iminoctadine [13516-27-3]+TX, azoxystrobin [131860-33-8]+TX, dimoxystrobin [149961-52-4]+TX, enestroburin {Proc. BCPC, Int. Congr., Glasgow, 2003, 1, 93}+TX, fluoxastrobin [361377-29-9]+TX, kresoxim-methyl [143390-89-0]+TX, metominostrobin [133408-50-1]+TX, trifloxystrobin [141517-21-7]+TX, orysastrobin [248593-16-0]+TX, picoxystrobin [117428-22-5]+TX, pyraclostrobin [175013-18-0]+TX, ferbam [14484-64-1]+TX, mancozeb [8018-01-7]+TX, maneb [12427-38-2]+TX, metiram [9006-42-2]+TX, propineb [12071-83-9]+TX, thiram [137-26-8]+TX, zineb [12122-67-7]+TX, ziram [137-30-4]+TX, captafol [2425-06-1]+TX, captan [133-06-2]+TX, dichlofluanid [1085-98-9]+TX, fluoroimide [41205-21-4]+TX, folpet [133-07-3]+TX, tolylfluanid [731-27-1]+TX, bordeaux mixture [8011-63-0]+TX, copperhydroxid [20427-59-2]+TX, copperoxychlorid [1332-40-7]+TX, coppersulfat [7758-98-7]+TX, copperoxid [1317-39-1]+TX, mancopper [53988-93-5]+TX, oxine-copper [10380-28-6]+TX, dinocap [131-72-6]+TX, nitrothal-isopropyl [10552-74-6]+TX, edifenphos [17109-49-8]+TX, iprobenphos [26087-47-8]+TX, isoprothiolane [50512-35-1]+TX, phosdiphen [36519-00-3]+TX, pyrazophos [13457-18-6]+TX, tolclofos-methyl [57018-04-9]+TX, acibenzolar-S-methyl [135158-54-2]+TX, anilazine [101-05-3]+TX, benthiavalicarb [413615-35-7]+TX, blasticidin-S [2079-00-7]+TX, chinomethionat [2439-01-2]+TX, chloroneb [2675-77-6]+TX, chlorothalonil [1897-45-6]+TX, cyflufenamid [180409-60-3]+TX, cymoxanil [57966-95-7]+TX, dichlone [117-80-6]+TX, diclocymet [139920-32-4]+TX, diclomezine [62865-36-5]+TX, dicloran [99-30-9]+TX, diethofencarb [87130-20-9]+TX, dimethomorph [110488-70-5]+TX, SYP-L190 (Flumorph) [211867-47-9]+TX, dithianon [3347-22-6]+TX, ethaboxam [162650-77-3]+TX, etridiazole [2593-15-9]+TX, famoxadone [131807-57-3]+TX, fenamidone [161326-34-7]+TX, fenoxanil [115852-48-7]+TX, fentin [668-34-8]+TX, ferimzone [89269-64-7]+TX, fluazinam [79622-59-6]+TX, fluopicolide [239110-15-7]+TX, flusulfamide [106917-52-6]+TX, fenhexamid [126833-17-8]+TX, fosetyl-aluminium [39148-24-8]+TX, hymexazol [10004-44-1]+TX, iprovalicarb [140923-17-7]+TX, IKF-916 (Cyazofamid) [120116-88-3]+TX, kasugamycin [6980-18-3]+TX, methasulfocarb [66952-49-6]+TX, metrafenone [220899-03-6]+TX, pencycuron [66063-05-6]+TX, phthalide [27355-22-2]+TX, polyoxins [11113-80-7]+TX, probenazole [27605-76-1]+TX, propamocarb [25606-41-1]+TX, proquinazid [189278-12-4]+TX, pyroquilon [57369-32-1]+TX, quinoxyfen [124495-18-7]+TX, quintozene [82-68-8]+TX, sulfur [7704-34-9]+TX, tiadinil [223580-51-6]+TX, triazoxide [72459-58-6]+TX, tricyclazole [41814-78-2]+TX, triforine [26644-46-2]+TX, validamycin [37248-47-8]+TX, zoxamide (RH7281) [156052-68-5]+TX, mandipropamid [374726-62-2]+TX, isopyrazam [881685-58-1]+TX, sedaxane [874967-67-6]+TX, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide (disclosed in WO 2007/048556)+TX, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (3′,4′,5′-trifluoro-biphenyl-2-yl)-amide (disclosed in WO 2006/087343)+TX, [(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-3-[(cyclopropylcarbonyl)oxy]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-6,12-dihydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11Hnaphtho[2,1-b]pyrano[3,4-e]pyran-4-yl]methyl-cyclopropanecarboxylate [915972-17-7]+TX, 1,3,5-trimethyl-N-(2-methyl-1-oxopropyl)-N-[3-(2-methylpropyl)-4-[2,2,2-trifluoro-1-methoxy-1-(trifluoromethyl)ethyl]phenyl]-1H-pyrazole-4-carboxamide [926914-55-8]+TX, lancotrione [1486617-21-3]+TX, florpyrauxifen [943832-81-3]+TX, ipfentrifluconazole[1417782-08-1]+TX, mefentrifluconazole [1417782-03-6]+TX, quinofumelin [861647-84-9]+TX, chloroprallethrin [399572-87-3]+TX, cyhalodiamide [1262605-53-7]+TX, fluazaindolizine [1254304-22-7]+TX, fluxametamide [928783-29-3]+TX, epsilon-metofluthrin [240494-71-7]+TX, epsilon-momfluorothrin [1065124-65-3]+TX, pydiflumetofen [1228284-64-7]+TX, kappa-bifenthrin [439680-76-9]+TX, broflanilide [1207727-04-5]+TX, dicloromezotiaz [1263629-39-5]+TX, dipymetitrone [16114-35-5]+TX, pyraziflumid [942515-63-1]+TX and kappa-tefluthrin [391634-71-2]+TX; and microbials including: Plant extracts including: pine oil (Retenol®)+TX, azadirachtin (Plasma Neem Oil®+TX, AzaGuard®+TX, MeemAzal®+TX, Molt-X®+TX, Botanical IGR (Neemazad®+TX, Neemix®)+TX, canola oil (Lilly Miller Vegol®)+TX, pheromones including: blackheaded fireworm pheromone (3M Sprayable Blackheaded Fireworm Pheromone®)+TX, Codling Moth Pheromone (Paramount dispenser-(CM)/Isomate C-Plus®)+TX, Grape Berry Moth Pheromone (3M MEC-GBM Sprayable Pheromone®)+TX, Leafroller pheromone (3M MEC—LR Sprayable Pheromone®)+TX, Muscamone (Snip7 Fly Bait®+TX, Starbar Premium Fly Bait®)+TX, Oriental Fruit Moth Pheromone (3M oriental fruit moth sprayable Pheromone®)+TX, Peachtree Borer Pheromone (Isomate-P®)+TX, Tomato Pinworm Pheromone (3M Sprayable Pheromone®)+TX, Entostat powder (extract from palm tree) (Exosex CM®)+TX, (E+TX,Z+TX,Z)-3+TX,8+TX,11 Tetradecatrienyl acetate+TX, (Z+TX,Z+TX,E)-7+TX,11+TX,13-Hexadecatrienal+TX, (E+TX,Z)-7+TX,9-Dodecadien-1-yl acetate+TX, 2-Methyl-1-butanol+TX, Calcium acetate+TX, Scenturion®+TX, Biolure®+TX, Check-Mate®+TX, Lavandulyl senecioate; and Macrobials including: other biologicals including: abscisic acid+TX, bioSea®+TX, or a biologically active compound or agent selected from: Brofluthrinate+TX, Diflovidazine+TX, Flometoquin+TX, Fluhexafon+TX, or an active substance referenced by a code+TX, such as code AE 1887196 (BSC-BX60309)+TX, code NNI-0745 GR+TX, code IKI-3106+TX, code JT-L001+TX, code ZNQ-08056+TX, code IPPA152201+TX, code HNPC-A9908 (CAS: [660411-21-2])+TX, code HNPC-A2005 (CAS: [860028-12-2])+TX, code JS118+TX, code ZJ0967+TX, code ZJ2242+TX, code JS7119 (CAS: [929545-74-4])+TX, code SN-1172+TX, code HNPC-A9835+TX, code HNPC-A9955+TX, code HNPC-A3061+TX, code Chuanhua 89-1+TX, code IPP-10+TX, code ZJ3265+TX, code JS9117+TX, code ZJ3757+TX, code ZJ4042+TX, code ZJ4014+TX, code ITM-121+TX, code DPX-RAB55 (DKI-2301)+TX, code NA-89+TX, code MIE-1209+TX, code MCI-8007+TX, code BCS-CL73507+TX, code S-1871+TX, code DPX-RDS63+TX, Quinofumelin+TX, mefentrifluconazol+TX, fenpicoxamid+TX, fluindapyr+TX, inpyrfluxam+TX or indiflumetpyr+TX, isoflucypram+TX, pyrapropoyne+TX, florylpicoxamid+TX, metyltetraprole+TX, ipflufenoquin+TX, pyridachlometyl+TX or chlopyridiflu+TX, tetrachlorantraniliprole+TX, tetrachloraniliprole+TX, Tyclopyrazoflor+TX, flupyrimin+TX or pyrifluramide+TX, benzpyrimoxan+TX, Benzosufyl+TX or oxazosulfyl+TX, etpyrafen+TX, acynonapyr+TX or pyrinonafen+TX, oxotrione+TX, bixlozone+TX or clofendizone+TX or dicloroxizone+TX, cyclopyranil+TX or pyrazocyclonil+TX or cyclopyrazonil+TX, alpha-bromadiolone+TX, and code AKD-1193+TX. The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The above described mixing partners are known. Where the active ingredients are included in “The Pesticide Manual” [The Pesticide Manual—A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound “abamectin” is described under entry number (1). Where “[CCN]” is added hereinabove to the particular compound, the compound in question is included in the “Compendium of Pesticide Common Names”, which is accessible on the internet [A. Wood; Most of the active ingredients described above are referred to hereinabove by a so-called “common name”, the relevant “ISO common name” or another “common name” being used in individual cases. If the designation is not a “common name”, the nature of the designation used instead is given in round brackets for the particular compound; in that case, the IUPAC name, the IUPAC/Chemical Abstracts name, a “chemical name”, a “traditional name”, a “compound name” or a “develoment code” is used or, if neither one of those designations nor a “common name” is used, an “alternative name” is employed. “CAS Reg. No” means the Chemical Abstracts Registry Number. The active ingredient mixture of the compounds of formula I selected from Tables 1 to 12 and Table P with active ingredients described above comprises a compound selected from Tables 1 to 12 and Table P and an active ingredient as described above preferably in a mixing ratio of from 100:1 to 1:6000, especially from 50:1 to 1:50, more especially in a ratio of from 20:1 to 1:20, even more especially from 10:1 to 1:10, very especially from 5:1 and 1:5, special preference being given to a ratio of from 2:1 to 1:2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1:1, or 5:1, or 5:2, or 5:3, or 5:4, or 4:1, or 4:2, or 4:3, or 3:1, or 3:2, or 2:1, or 1:5, or 2:5, or 3:5, or 4:5, or 1:4, or 2:4, or 3:4, or 1:3, or 2:3, or 1:2, or 1:600, or 1:300, or 1:150, or 1:35, or 2:35, or 4:35, or 1:75, or 2:75, or 4:75, or 1:6000, or 1:3000, or 1:1500, or 1:350, or 2:350, or 4:350, or 1:750, or 2:750, or 4:750. Those mixing ratios are by weight. The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body. The mixtures comprising a compound of formula I selected from Tables 1 to 12 and Table P and one or more active ingredients as described above can be applied, for example, in a single “ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a “tank-mix”, and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the compounds of formula I selected from Tables 1 to 12 and Table P and the active ingredients as described above is not essential for working the present invention. The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides. The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds I for the preparation of these compositions are also a subject of the invention. The application methods for the compositions, that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring—which are to be selected to suit the intended aims of the prevailing circumstances—and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention. Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha. A preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question. Alternatively, the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field. The compounds of the invention and compositions thereof are also be suitable for the protection of plant propagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type. The propagation material can be treated with the compound prior to planting, for example seed can be treated prior to sowing. Alternatively, the compound can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling. These treatment methods for plant propagation material and the plant propagation material thus treated are further subjects of the invention. Typical treatment rates would depend on the plant and pest/fungi to be controlled and are generally between 1 to 200 grams per 100 kg of seeds, preferably between 5 to 150 grams per 100 kg of seeds, such as between 10 to 100 grams per 100 kg of seeds. The term seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corns, bulbs, fruit, tubers, grains, rhizomes, cuttings, cut shoots and the like and means in a preferred embodiment true seeds. The present invention also comprises seeds coated or treated with or containing a compound of formula I. The term “coated or treated with and/or containing” generally signifies that the active ingredient is for the most part on the surface of the seed at the time of application, although a greater or lesser part of the ingredient may penetrate into the seed material, depending on the method of application. When the said seed product is (re)planted, it may absorb the active ingredient. In an embodiment, the present invention makes available a plant propagation material adhered thereto with a compound of formula (I). Further, it is hereby made available, a composition comprising a plant propagation material treated with a compound of formula (I). Seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting. The seed treatment application of the compound formula (I) can be carried out by any known methods, such as spraying or by dusting the seeds before sowing or during the sowing/planting of the seeds. The Examples which follow serve to illustrate the invention. Certain compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 25 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm, 0.8 ppm, 0.2 ppm or 0.05 ppm. 24-well microtiter plates with artificial diet were treated with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions by pipetting. After drying, the plates were infested with L2 larvae (10 to 15 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation. The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P1, P3, P4, P6, P7, P8, P9, P10, P12, P13, P14, P15, P16, P17, P18, P19, P21, P22, P23, P24. Sunflower leaf discs were placed on agar in a 24-well microtiter plate and sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying, the leaf discs were infested with an aphid population of mixed ages. The samples were assessed for mortality 6 days after infestation. The following compounds resulted in at least 80% mortality at an application rate of 200 ppm: P1, P2, P3, P4, P5, P6, P7, P8, P9, P10, P12, P13, P14, P15, P16, P17, P18, P19, P22, P23. Roots of pea seedlings infested with an aphid population of mixed ages were placed directly in the aqueous test solutions prepared from 10′000 DMSO stock solutions. The samples were assessed for mortality 6 days after placing seedlings in test solutions. The following compounds resulted in at least 80% mortality at a test rate of 24 ppm: P1, P2, P3, P4, P5, P6, P7, P8, P9, P10, P12, P13, P14, P15, P16, P17, P18, P19, P22, P23. Sunflower leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10′000 DMSO stock solutions. After drying the leaf discs were infested with a The following compounds resulted in at least 80% mortality at an application rate of 200 ppm: P1, P4, P7, P8, P9, P10, P14, P15, P19, P22. Cotton leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying the leaf discs were infested with adult white flies. The samples were checked for mortality 6 days after incubation. The following compounds resulted in at least 80% mortality at an application rate of 200 ppm: P1, P3, P4, P5, P6, P8, P9, P10, P12, P14, P15, P16, P18, P19, P22, P23. Soybean leaf on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying the leaf were infested with N-2 nymphs. The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation. The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P1, P2, P3, P4, P5, P6, P8, P9, P10, P13, P14, P15, P16, P17, P18, P19, P21, P22, P23. Maize sprouts placed onto an agar layer in 24-well microtiter plates were treated with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions by spraying. After drying, the plates were infested with L2 larvae (6 to 10 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 4 days after infestation. The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P1, P4, P5, P6, P7, P8, P9, P13, P14, P15, P16, P18, P22, P23, P24. Cotton leaf discs were placed onto agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying the leaf discs were infested with five L1 larvae. The samples were assessed for mortality, anti-feeding effect, and growth inhibition in comparison to untreated samples 3 days after infestation. Control of The following compound resulted in at least 80% control at an application rate of 200 ppm: P4, P8, P13, P14, P15, P16, P21, P24. Sunflower leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying the leaf discs were infested with a The following compound resulted in at least 80% mortality at an application rate of 200 ppm: P1. Compounds of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides and can be prepared in a manner known per se. 1. A compound of formula I wherein A is CH or N; X is S, SO or SO2; R1 is C1-C4alkyl, C1-C4haloalkyl or C3-C6cycloalkyl-C1-C4alkyl; R7 and R8 are, independently from each other, C1-C6alkyl, C1-C6haloalkyl, C3-C6cycloalkyl, C1-C6cyanoalkyl, C1-C4alkoxyC1-C4alkyl, pyridyl or phenyl, wherein said pyridyl or phenyl can be mono- or polysubstituted by substituents selected from the group consisting of halogen, cyano, C1-C4alkyl, C1-C4haloalkyl, C1-C4haloalkoxy, C1-C4alkoxy, C1-C4haloalkylsulfanyl, C1-C4haloalkylsulfinyl, C1-C4haloalkylsulfonyl and —C(O)C1-C4haloalkyl; or R7 and R8, together with the sulfur atom to which they are attached, form a four- to six-membered, saturated ring system, said ring system can be mono- or polysubstituted by substituents selected from the group consisting of halogen, cyano, C1-C4alkyl, C1-C4alkoxy and C1-C4haloalkyl; and said ring system may contain one heteroatom selected from the group consisting of nitrogen, oxygen and sulfur; n is 0 or 1; Q is a radical selected from the group consisting of formula Q1 to Q4 wherein the arrow denotes the point of attachment to the ring incorporating the radical A; and wherein X1 is O, S or NR3, wherein R3 is C1-C4alkyl; R2 is halogen, C1-C6haloalkyl, C1-C4haloalkylsulfanyl, C1-C4haloalkylsulfinyl, C1-C4haloalkylsulfonyl or C1-C6haloalkoxy; G1 is N or CH; G2 and G3 are, independently from each other, N or CH; and agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula I. 2. A compound of formula I according to wherein Q, A, n, R7 and R8 are as defined under formula I in Xa1 is S, SO or SO2; and Ra1 is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. 3. A compound of formula I according to wherein X1, R2, G1, A, n, R7 and R8 are as defined under formula I in Xa2 is S, SO or SO2; and Ra2 is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. 4. A compound of formula I according to wherein A is N; R2 is C1-C6haloalkyl; G1 is N or CH; n is 0 or 1; R7 and R8 are, independently from each other, C1-C6alkyl; or R7 and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system which can contain one oxygen atom. 5. A compound of formula I according to wherein R2, G3, A, n, R7 and R8 are as defined under formula I in Xa3 is S, SO or SO2; and Ra3 is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. 6. A compound of formula I according to wherein A is CH or N; R2 is C1-C6haloalkyl; G3 is N or CH; n is 0 or 1; and R7 and R8 are, independently from each other, C1-C6alkyl; or R7 and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, which can contain one oxygen atom. 7. A compound of formula I according to wherein X1, R2, G1, A, n, R7 and R8 are as defined under formula I in Xa4 is S, SO or SO2; and Ra4 is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl. 8. A compound of formula I according to wherein A is N; R2 is C1-C6haloalkyl; G1 is N or CH; n is 0 or 1; and R7 and R8 are, independently from each other, C1-C6alkyl; or R7 and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, which can contain one oxygen atom. 9. A compound of formula I according to wherein A is CH or N; n is 0 or 1; R7 and R8 are, independently from each other, C1-C6alkyl; or R7 and R8, together with the sulfur atom to which they are attached, form a six-membered, saturated ring system, which can contain one oxygen atom; and Q is a radical selected from the group consisting of formula Q1a, Q1b and Q2a wherein the arrow denotes the point of attachment to the ring incorporating the radical A; and in which R2 is C1-C6haloalkyl. 10. A pesticidal composition, which comprises at least one compound of formula I according to 11. A method for controlling pests, which comprises applying a composition according to 12. A method for the protection of plant propagation material from the attack by pests, which comprises treating the propagation material or the site, where the propagation material is planted, with a composition according to 1.001 N —CH2CH3 CH CF3 1 CH3 CH3 1.002 N —CH2CH3 CH CF3 1 CH3 CH2CH3 1.003 N —CH2CH3 CH CF3 1 CH2CH3 CH2CH3 1.004 N —CH2CH3 CH CF3 1 —CH2CH2CH2— 1.005 N —CH2CH3 CH CF3 1 —CH2CH2OCH2CH2— 1.006 N —CH2CH3 N CF3 1 CH3 CH3 1.007 N —CH2CH3 N CF3 1 CH3 CH2CH3 1.008 N —CH2CH3 N CF3 1 CH2CH3 CH2CH3 1.009 N —CH2CH3 N CF3 1 —CH2CH2CH2— 1.010 N —CH2CH3 N CF3 1 —CH2CH2OCH2CH2— 1.011 N —CH2CH3 CH CF3 0 CH3 CH3 1.012 N —CH2CH3 CH CF3 0 CH3 CH2CH3 1.013 N —CH2CH3 CH CF3 0 CH2CH3 CH2CH3 1.014 N —CH2CH3 N CF3 0 CH3 CH3 1.015 N —CH2CH3 N CF3 0 CH3 CH2CH3 1.016 N —CH2CH3 N CF3 0 CH2CH3 CH2CH3 1.017 CH —CH2CH3 CH CF3 1 CH3 CH3 1.018 CH —CH2CH3 CH CF3 1 CH3 CH2CH3 1.019 CH —CH2CH3 CH CF3 1 CH2CH3 CH2CH3 1.020 CH —CH2CH3 N CF3 1 CH3 CH3 1.021 CH —CH2CH3 N CF3 1 CH3 CH2CH3 1.022 CH —CH2CH3 N CF3 1 CH2CH3 CH2CH3 1.023 CH —CH2CH3 CH CF3 0 CH3 CH3 1.024 CH —CH2CH3 CH CF3 0 CH3 CH2CH3 1.025 CH —CH2CH3 CH CF3 0 CH2CH3 CH2CH3 1.026 CH —CH2CH3 N CF3 0 CH3 CH3 1.027 CH —CH2CH3 N CF3 0 CH3 CH2CH3 1.028 CH —CH2CH3 N CF3 0 CH2CH3 CH2CH3
and the N-oxides of the compounds of Table 1.
4.001 N —CH2CH3 N CF3 1 CH3 CH3 4.002 N —CH2CH3 N CF3 1 CH3 CH2CH3 4.003 N —CH2CH3 N CF3 1 CH2CH3 CH2CH3 4.004 N —CH2CH3 N CF3 1 —CH2CH2CH2— 4.005 N —CH2CH3 N CF3 1 —CH2CH2OCH2CH2— 4.006 CH —CH2CH3 N CF3 1 CH3 CH3 4.007 CH —CH2CH3 N CF3 1 CH3 CH2CH3 4.008 CH —CH2CH3 N CF3 1 CH2CH3 CH2CH3 4.009 N —CH2CH3 N CF3 0 CH3 CH3 4.010 N —CH2CH3 N CF3 0 CH2CH3 CH3 4.011 N —CH2CH3 N CF3 0 CH2CH3 CH2CH3 4.012 CH —CH2CH3 N CF3 0 CH3 CH3 4.013 CH —CH2CH3 N CF3 0 CH2CH3 CH3 4.014 CH —CH2CH3 N CF3 0 CH2CH3 CH2CH3 4.015 N —CH2CH3 CH CF3 1 CH3 CH3 4.016 N —CH2CH3 CH CF3 1 CH3 CH2CH3 4.017 N —CH2CH3 CH CF3 1 CH2CH3 CH2CH3 4.018 CH —CH2CH3 CH CF3 1 CH3 CH3 4.019 CH —CH2CH3 CH CF3 1 CH3 CH2CH3 4.020 CH —CH2CH3 CH CF3 1 CH2CH3 CH2CH3 4.021 N —CH2CH3 CH CF3 0 CH3 CH3 4.022 N —CH2CH3 CH CF3 0 CH2CH3 CH3 4.023 N —CH2CH3 CH CF3 0 CH2CH3 CH2CH3 4.024 CH —CH2CH3 CH CF3 0 CH3 CH3 4.025 CH —CH2CH3 CH CF3 0 CH2CH3 CH3 4.026 CH —CH2CH3 CH CF3 0 CH2CH3 CH2CH3
and the N-oxides of the compounds of Table 4.
7.001 N —CH2CH3 N CF3 1 CH3 CH3 7.002 N —CH2CH3 N CF3 1 CH3 CH2CH3 7.003 N —CH2CH3 N CF3 1 CH2CH3 CH2CH3 7.004 N —CH2CH3 N CF3 1 —CH2CH2CH2— 7.005 N —CH2CH3 N CF3 1 —CH2CH2OCH2CH2— 7.006 N —CH2CH3 N CF3 0 CH3 CH3 7.007 N —CH2CH3 N CF3 0 CH3 CH2CH3 7.008 N —CH2CH3 N CF3 0 CH2CH3 CH2CH3 7.009 CH —CH2CH3 N CF3 1 CH3 CH3 7.010 CH —CH2CH3 N CF3 1 CH3 CH2CH3 7.011 CH —CH2CH3 N CF3 1 CH2CH3 CH2CH3 7.012 CH —CH2CH3 N CF3 0 CH3 CH3 7.013 CH —CH2CH3 N CF3 0 CH3 CH2CH3 7.014 CH —CH2CH3 N CF3 0 CH2CH3 CH2CH3 7.015 N —CH2CH3 CH CF3 1 CH3 CH3 7.016 N —CH2CH3 CH CF3 1 CH3 CH2CH3 7.017 N —CH2CH3 CH CF3 1 CH2CH3 CH2CH3 7.018 N —CH2CH3 CH CF3 0 CH3 CH3 7.019 N —CH2CH3 CH CF3 0 CH3 CH2CH3 7.020 N —CH2CH3 CH CF3 0 CH2CH3 CH2CH3 7.021 CH —CH2CH3 CH CF3 1 CH3 CH3 7.022 CH —CH2CH3 CH CF3 1 CH3 CH2CH3 7.023 CH —CH2CH3 CH CF3 1 CH2CH3 CH2CH3 7.024 CH —CH2CH3 CH CF3 0 CH3 CH3 7.025 CH —CH2CH3 CH CF3 0 CH3 CH2CH3 7.026 CH —CH2CH3 CH CF3 0 CH2CH3 CH2CH3
and the N-oxides of the compounds of Table 7.
10.001 N —CH2CH3 CH N CF3 1 CH3 CH3 10.002 N —CH2CH3 CH N CF3 1 CH3 CH2CH3 10.003 N —CH2CH3 CH N CF3 1 CH2CH3 CH2CH3 10.004 N —CH2CH3 CH N CF3 1 —CH2CH2CH2— 10.005 N —CH2CH3 CH N CF3 1 —CH2CH2OCH2CH2— 10.006 N —CH2CH3 CH N CF3 0 CH3 CH3 10.007 N —CH2CH3 CH N CF3 0 CH3 CH2CH3 10.008 N —CH2CH3 CH N CF3 0 CH2CH3 CH2CH3 10.009 CH —CH2CH3 CH N CF3 1 CH3 CH3 10.010 CH —CH2CH3 CH N CF3 1 CH3 CH2CH3 10.011 CH —CH2CH3 CH N CF3 1 CH2CH3 CH2CH3 10.012 CH —CH2CH3 CH N CF3 0 CH3 CH3 10.013 CH —CH2CH3 CH N CF3 0 CH3 CH2CH3 10.014 CH —CH2CH3 CH N CF3 0 CH2CH3 CH2CH3
and the N-oxides of the compounds of Table 10.
Examples of exotic woodborers of economic importance. Host or Crop Family Species Infested Buprestidae Ash Cerambycidae Hardwoods Scolytidae Hardwoods Hardwoods Conifers Examples of native woodborers of economic importance. Family Species Host or Crop Infested Buprestidae Birch Willow, Maple Bayberry, Sweetfern Apple, Pear, Cranberry, Serviceberry, Hawthorn Apple, Apricot, Beech, Boxelder, Cherry, Chestnut, Currant, Elm, Hawthorn, Hackberry, Hickory, Horsechestnut, Linden, Maple, Mountain-ash, Oak, Pecan, Pear, Peach, Persimmon, Plum, Poplar, Quince, Redbud, Serviceberry, Sycamore, Walnut, Willow Basswood, Beech, Maple, Oak, Sycamore, Willow, Yellow-poplar Cerambycidae Beech, Elm, Nuttall, Willow, Black oak, Cherrybark oak, Water oak, Sycamore Oak Ash, Hickory, Oak, Walnut, Birch, Beech, Maple, Eastern hophornbeam, Dogwood, Persimmon, Redbud, Holly, Hackberry, Black locust, Honeylocust, Yellow-poplar, Chestnut, Osage-orange, Sassafras, Lilac, Mountain-mahogany, Pear, Cherry, Plum, Peach, Apple, Elm, Basswood, Sweetgum Fig, Alder, Mulberry, Willow, Netleaf hackberry Sumac, Apple, Peach, Plum, Pear, Currant, Blackberry Dogwood, Viburnum, Elm, Sourwood, Blueberry, Rhododendron, Azalea, Laurel, Poplar, Willow, Mulberry Hickory, Pecan, Persimmon, Elm, Sourwood, Basswood, Honeylocust, Dogwood, Eucalyptus, Oak, Hackberry, Maple, Fruit trees Poplar Chestnut, Oak, Hickory, Walnut, Beech, Maple Scolytidae Maple, Oak, Yellow-poplar, Beech, Boxelder, Sycamore, Birch, Basswood, Chestnut, Elm Pine Birch, Sweetgum, Wild cherry, Beech, Pear Oak, Maple, Birch, Chestnut, Sweetgum, Blackgum, Poplar, Hickory, Mimosa, Apple, Peach, Pine Peach, Cherry, Plum, Black cherry, Elm, Mulberry, Mountain-ash Oak, American beech, Black cherry, Chickasaw plum, Chestnut, Maple, Hickory, Hornbeam, Hophornbeam Sesiidae Oak, American chestnut Persimmon Peach, Plum, Nectarine, Cherry, Apricot, Almond, Black cherry Peach, Plum, Cherry, Beach, Black Cherry Tupelo Dogwood, Pecan, Hickory, Oak, Chestnut, Beech, Birch, Black cherry, Elm, Mountain-ash, Viburnum, Willow, Apple, Loquat, Ninebark, Bayberry Grape Emulsifiable Concentrates:
Dusts:
Suspension Concentrates:
Wettable Powders:
Granules:
active ingredients 25% 50% 75% sodium lignosulfonate 5% 5% — sodium lauryl sulfate 3% — 5% sodium diisobutylnaphthalenesulfonate — 6% 10% phenol polyethylene glycol ether — 2% — (7-8 mol of ethylene oxide) highly dispersed silicic acid 5% 10% 10% Kaolin 62% 27% — active ingredients 25% 50% 75% light mineral oil 5% 5% 5% highly dispersed silicic acid 5% 5% — Kaolin 65% 40% — Talcum — 20% active ingredients 10% octylphenol polyethylene glycol 3% ether (4-5 mol of ethylene oxide) calcium dodecylbenzenesulfonate 3% castor oil polyglycol ether (35 mol of 4% ethylene oxide) Cyclohexanone 30% xylene mixture 50% Active ingredients 5% 6% 4% Talcum 95% — — Kaolin — 94% — mineral filler — — 96% Active ingredients 15% sodium lignosulfonate 2% carboxymethylcellulose 1% Kaolin 82% Active ingredients 8% polyethylene glycol (mol. wt. 200) 3% Kaolin 89% Suspension Concentrate
active ingredients 40% propylene glycol 10% nonylphenol polyethylene glycol ether 6% (15 mol of ethylene oxide) Sodium lignosulfonate 10% carboxymethylcellulose 1% silicone oil (in the form of a 75% 1% emulsion in water) Water 32% Flowable Concentrate for Seed Treatment
active ingredients 40% propylene glycol 5% copolymer butanol PO/EO 2% Tristyrenephenole with 10-20 moles EO 2% 1,2-benzisothiazolin-3-one (in the form 0.5% of a 20% solution in water) monoazo-pigment calcium salt 5% Silicone oil (in the form of a 75% 0.2% emulsion in water) Water 45.3% Slow Release Capsule Suspension
PREPARATORY EXAMPLES
LCMS and GCMS Methods:
Method 1:
Method 2:
Method 3:
Method 4:
a) Synthesis of Examples of Compounds of Formula (I)
Example P-P1: Preparation of N-(ethyl-methyl-oxo-λ6-sulfanylidene)-5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxamide (Compound P8)
Example P-P2: Preparation of N-(dimethyl-λ4-sulfanylidene)-5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxamide (Compound P5)
Example P-P3: Preparation of N-[dimethyl(oxo)-λ6-sulfanylidene]-5-ethylsulfonyl-6-[6-(trifluoromethyl)pyrazolo[4,3-c]pyridin-2-yl]pyridine-3-carboxamide (Compound P24)
Examples of compounds of formula (I) LCMS Rt [M + H]+ Mp No. IUPAC name Structures (min) (measured) Method (° C.) P1 N-[dimethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2- yl]pyridine-3-carboxamide 0.83 490 1 202-204 P2 5-ethylsulfonyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]-N-(4-oxo-1,4- oxathian-4-ylidene)pyridine-3- carboxamide 0.86 532 1 214-216 P3 N-[diethyl(oxo))-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2- yl]pyridine-3-carboxamide 0.90 518 1 111-113 P4 N-[dimethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[7- (trifluoromethyl)imidazo[1,2- c]pyrimidin-2-yl]pyridine-3- carboxamide 0.81 476 1 237-238 P5 N-(dimethyl-λ4-sulfanylidene)- 5-ethylsulfonyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]pyridine-3- carboxamide 0.79 474 1 P6 N-[dimethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[7- methyl-3-(trifluoromethyl) imidazo[4,5-c]pyridazin-6- yl]pyridine-3-carboxamide 0.83 491 1 197-198 P7 N-[dimethyl(oxo)-λ6- sulfanylidene]- 3-ethylsulfonyl-4-[7- (trifluoromethyl)imidazo[1,2- c]pyrimidin-2-yl]benzamide 0.83 475 1 187-189 P8 N-(ethyl-methyl-oxo-λ6- sulfanylidene)- 5-ethylsulfonyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2- yl]pyridine-3-carboxamide 0.87 504 1 113-114 P9 N-(ethyl-methyl-oxo-λ6- sulfanylidene)- 5-ethylsulfonyl-6-[7- methyl-3-(trifluoromethyl) imidazo[4,5-c]pyridazin-6- yl]pyridine-3-carboxamide 0.85 505 1 215-217 P10 N-(diethyl-λ4-sulfanylidene)-5- ethylsulfonyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]pyridine-3- carboxamide 0.86 502 1 P11 N-(dimethyl-λ4-sulfanylidene)- 5-ethylsulfonyl-6-[7-(trifluoro- methyl)imidazo[1,2-c] pyrimidin-2-yl]pyridine-3- carboxamide 0.76 460 1 P12 5-ethylsulfonyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]-N- (1-oxothietan- 1-ylidene)pyridine-3- carboxamide 0.87 502 1 210-212 P13 5-ethylsulfonyl-N-(1- oxothietan-1-ylidene)-6-[7- (trifluoromethyl)imidazo[1,2- c]pyrimidin-2-yl]pyridine-3- carboxamide 0.85 488 1 200-202 P14 N-[dimethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]pyridine-3-carboxamide 0.90 490 1 P15 N-(ethyl-methyl-oxo-λ6- sulfanylidene)- 5-ethylsulfonyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]pyridine-3-carboxamide 0.94 504 1 P16 5-ethylsulfonyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- b]pyridin-2-yl]-N- (1-oxothietan- 1-ylidene)pyridine-3- carboxamide 0.94 502 1 P17 5-ethylsulfonyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- b]pyridin-2-yl]-N-(4-oxo-1,4- oxathian-4-ylidene)pyridine-3- carboxamide 0.92 532 1 P18 N-[diethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[7- methyl-3-(trifluoromethyl) imidazo[4,5-c]pyridazin-6- yl]pyridine-3-carboxamide 0.89 519 1 187-189 P19 N-[diethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]pyridine-3-carboxamide 0.96 518 1 152-155 P20 N-[dimethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[7- (trifluoromethyl)imidazo[1,2- a]pyridin-2-yl]pyridine-3- carboxamide P21 N-[diethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[7- (trifluoromethyl)imidazo[1,2- c]pyrimidin-2-yl]pyridine-3- carboxamide 0.86 504 1 214-218 P22 N-[dimethyl(oxo)-λ6- sulfanylidene]- 3-ethylsulfonyl-4-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]benzamide 0.87 489 1 241-242 P23 N-[diethyl(oxo)-λ6- sulfanylidene]- 3-ethylsulfonyl-4-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]benzamide 0.93 517 1 192-193 P24 N-[dimethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[6- (trifluoromethyl)pyrazolo[4,3- c]pyridin-2-yl]pyridine-3- carboxamide 1.41 476 3 268-270 P25 N-(ethyl-methyl-oxo-λ6- sulfanylidene)- 5-ethylsulfonyl-6-[6- (trifluoromethyl)pyrazolo[4,3- c]pyridin-2-yl]pyridine-3- carboxamide 0.88 490 1 216-219 P26 N-[diethyl(oxo)-λ6- sulfanylidene]- 5-ethylsulfonyl-6-[6- (trifluoromethyl)pyrazolo[4,3- c]pyridin-2-yl]pyridine-3- carboxamide 0.91 504 1 185-189 b) Synthesis of Intermediates
Example P-I1: Preparation of 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carbonyl chloride (Intermediate I3) and 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxamide (Intermediate I4)
Step P-I1.1: Synthesis of methyl 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxylate (Intermediate I1)
Step P-I1.2: Synthesis of 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxylic Acid (Intermediate I2)
Step P-I1.3: Synthesis of 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carbonyl Chloride (Intermediate I3)
Step P-I1.4: Synthesis of 5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-3-carboxamide (Intermediate I4)
Example P-I2: Preparation of 3-ethylsulfonyl-4-[7-(trifluoromethyl)imidazo[1,2-c]pyrimidin-2-yl]benzoic Acid (Intermediate I13)
Example P-I3: Preparation of 5-ethylsulfonyl-6-[7-methyl-3-(trifluoromethyl)imidazo[4,5-c]pyridazin-6-yl]pyridine-3-carboxylic Acid (Intermediate I10)
Step P-I3.1: Synthesis of 5-ethylsulfonyl-6-[7-methyl-3-(trifluoromethyl)imidazo[4,5-c]pyridazin-6-yl]pyridine-3-carbonitrile (Intermediate I9)
Step P-I3.2: Synthesis of 5-ethylsulfonyl-6-[7-methyl-3-(trifluoromethyl)imidazo[4,5-c]pyridazin-6-yl]pyridine-3-carboxylic Acid (Intermediate I10)
Example P-I4: Preparation of 5-ethylsulfonyl-6-[6-(trifluoro-methyl)pyrazolo[4,3-c]pyridin-2-yl]pyridine-3-carboxylic Acid (Intermediate I15)
Step P-I4.1: Synthesis of 2-(3-ethylsulfonyl-5-vinyl-2-pyridyl)-6-(trifluoromethyl)pyrazolo[4,3-c]pyridine
Step P-I4.2: Synthesis of 5-ethylsulfonyl-6-[6-(trifluoro-methyl)pyrazolo[4,3-c]pyridin-2-yl]pyridine-3-carboxylic Acid (Intermediate I15)
Examples of intermediate compounds of formula (II), (IV), (VIII), (IX) and (XI) LCMS [M + H]+ No. IUPAC name Structures Rt(min) (measured) Method Mp (° C.) I1 Methyl 5-ethylsulfonyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2- yl]pyridine-3-carboxylate 0.94 429 1 200-202 I2 5-ethylsulfonyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]pyridine-3- carboxylic acid 0.78 415 1 313-314 I3 5-ethylsulfonyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]pyridine-3- carbonyl chloride 1H NMR characterization: see experimental part. I4 5-ethylsulfonyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]pyridine-3- carboxamide 0.76 414 1 251-252 I5 methyl 5-ethylsulfonyl-6-[7- (trifluoromethyl)imidazo[1,2- c]pyrimidin-2-yl]pyridine-3- carboxylate 0.92 415 1 230-231 I6 5-ethylsulfonyl-6-[7-(trifluoro- methyl)imidazo[1,2-c] pyrimidin-2-yl]pyridine-3- carboxylic acid 0.78 401 1 I7 5-ethylsulfonyl-6-[7-(trifluoro- methyl)imidazo[1,2-c] pyrimidin-2-yl]pyridine-3- carbonyl chloride 1H NMR (400 MHz, d6-acetone) δ ppm: 1.37 (3H), 4.17 (2H), 8.35 (1H), 8.93 (1H), 9.04 (1H), 9.45 (1H), 9.76 (1H). I8 5-ethylsulfonyl-6-[7-(trifluoro- methyl)imidazo[1,2-c] pyrimidin-2-yl]pyridine-3- carboxamide 0.74 400 1 215-216 I9 5-ethylsulfonyl-6-[7-methyl-3- (trifluoromethyl)imidazo[4,5- c]pyridazin-6-yl]pyridine-3- carbonitrile 0.87 397 1 I10 5-ethylsulfonyl-6-[7-methyl-3- (trifluoromethyl)imidazo[4,5- c]pyridazin-6-yl]pyridine-3- carboxylic acid 0.76 416 1 I11 5-ethylsulfonyl-6-[7-methyl-3- (trifluoromethyl)imidazo[4,5- c]pyridazin-6-yl]pyridine-3- carbonyl chloride LC-MS data (method 1) of an aliquot quench over methanol: 430 (M + H)+, retention time 0.91 min, consistent with the corresponding methyl ester (C16H14F3N5O4S, M: 429). I12 methyl 3-ethylsulfonyl-4-[7- (trifluoromethyl)imidazo[1,2- c]pyrimidin-2-yl]benzoate 0.95 414 1 263-265 I13 3-ethylsulfonyl-4-[7-(trifluoro- methyl)imidazo[1,2-c] pyrimidin-2-yl]benzoic acid 0.82 400 1 I14 3-ethylsulfonyl-4-[7-(trifluoro- methyl)imidazo[1,2-c] pyrimidin-2-yl]benzoyl chloride 1H NMR (400 MHz, d6-acetone) δ ppm: 1.20 (t, 3H), 3.62 (q, 2H), 8.24 (d, J = 8.1 Hz, 1H), 8.25 (s, 1H), 8.57 (dd, J = 8.1, 1.8 Hz, 1H), 8.84 (s, 1H), 8.88 (d, J = 1.8 Hz, 1H), 9.75 (s, 1H). I15 5-ethylsulfonyl-6-[6-(trifluoro- methyl)pyrazolo[4,3-c]pyridin- 2-yl]pyridine-3-carboxylic acid 1.32 401 3 BIOLOGICAL EXAMPLES
Example B1: Activity Against
Example B2: Activity Against
Example B3: Activity Against
Example B4: Activity Against
Example B5: Activity Against
Example B6: Activity Against
Example B7: Activity Against
Example B8: Activity Against
Example B9: Activity Against